Ondas od 30. června získal objednávky v hodnotě přes 270 milionů USD, čímž rozšířil objem nevyřízených zakázek a zlepšil viditelnost tržeb do roku 2027.
Ondas Inc. (NASDAQ:ONDS) is expanding its autonomous defense and security business through rising orders, acquisitions and broader customer adoption, while analysts point to the company’s exposure to several growing defense markets.
The company designs, develops, manufactures, sells and supports FullMAX software-defined radio (SDR) technology across the U.S., Israel and India. It operates through two segments — Ondas Networks and Ondas Autonomous Systems — giving it exposure to both communications infrastructure and autonomous systems use cases.
The stock slid almost 30% in 2026 due to widening financial losses and shareholder dilution from acquisitions, despite strong top-line revenue growth.
On Wednesday, Ondas announced that it had secured more than $165 million in orders from the second half of August through Oct. 1. Combined with roughly $105 million announced earlier in the third quarter, orders since June 30 exceeded $270 million.
The company said the new business expanded its backlog and strengthened revenue visibility into 2027.
Orders came from multiple regions and product categories, reflecting demand across Ondas’ autonomous defense and security portfolio.
$56 Million European Order Expands Precision Strike BusinessOndas also secured a $56 million European defense order for Electronic Safe & Arm Devices tied to a loitering munition program this week.
The contract marks Ondas’ first major defense order since acquiring GATE Technologies and Bron Technologies and expands its Precision Strike business.
The company is also pursuing additional opportunities across NATO and allied defense markets.
Ondas separately reported progress with ULTRA, a candidate for a U.S. Department of Defense program of record, and its IonStrike "Shahed Killer."
"Importantly, both ULTRA and IonStrike have captured strategically significant orders and are advancing through key customer validation milestones, which we believe can open substantially larger markets," CEO Eric Brock said.
Citizens Turns Bullish On OndasOn Oct. 5, Citizens initiated coverage of Ondas with an Outperform rating, describing the company as a diversified autonomous-systems platform positioned for growth.
The firm said Ondas participates in four high-growth submarkets within the broader autonomous-systems industry.
Ondas Targets a Broader Defense OpportunityOndas is expanding its manufacturing capacity, engineering capabilities and customer relationships as it targets more areas of autonomous defense.
The company sees opportunities across counter-drone systems, loitering munitions, surveillance, ground robotics, electronic warfare, AI-enabled command systems and infrastructure monitoring.
Ondas believes rising global defense spending and wider adoption of autonomous technologies are creating a multi-billion-dollar opportunity across defense, security and industrial markets.
Top ETF Exposure Defiance Drone and Modern Warfare ETF (NYSE:JEDI): 6.43% Weight REX Drone ETF (NASDAQ:DRNZ): 11.77% Weight Significance: Because Ondas carries such a heavy weight in these funds, any significant inflows or outflows for these ETFs will likely trigger automatic buying or selling of the stock.
ONDS Price ActionOndas shares were down 2.12% at $6.81 at publication on Friday, according to Benzinga Pro data.
Photo via Shutterstock
Read Next
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
SummaryZETA's stock price has jumped by roughly 67% in just 1 year. But I believe that ZETA's ride is far from over. ZETA's 44% top-line growth, 170 bps EBITDA margin expansion to 20%, and 17% ARPU growth underscore accelerating financial momentum. Despite a 35x forward P/E, I believe ZETA can grow into and potentially outpace its valuation, supported by strategic M&A and platform adoption. I expect double-digit total return with ZETA, so I've just bought some shares. mikkelwilliam/E+ via Getty Images
I invest a lot in technology. I mean, I've owned Microsoft (MSFT) for years now. I bought Nvidia (NVDA) in 2022. And I'm looking at over 1000% return with my Micron Technology (
5.78K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of ZETA, MSFT, NVDA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
The information, opinions, and thoughts included in this article do not constitute an investment recommendation or any form of investment advice.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
A month has gone by since the last earnings report for SailPoint, Inc. (SAIL - Free Report) . Shares have added about 13.5% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is SailPoint, Inc. due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for SailPoint, Inc. before we dive into how investors and analysts have reacted as of late.
SAIL Q2 Earnings Beat Estimates on Strong SaaS GrowthSailPoint reported fiscal second-quarter 2027 adjusted earnings of 9 cents per share, up 28.6% year over year and 12.5% above the Zacks Consensus Estimate of 8 cents. The quarter benefited from strong SaaS adoption and AI-driven solution demand.
Revenues rose 16.8% year over year to $309 million but missed the consensus mark by 0.51%. Dollar-based net retention was 113%, highlighting steady customer retention and expansion.
SAIL’s Q2 ARR Growth Stays RobustAnnual recurring revenue, or ARR, increased 25% year over year to $1.231 billion. SaaS ARR climbed 36% to $847 million, while net new SaaS ARR rose 34% to $66 million and represented 97% of total net new ARR.
AI-driven ARR exceeded $70 million. AI-driven solutions accounted for more than 30% of net new ARR, while more than two-thirds of migrations completed in the quarter included an AI-driven solution.
The AI-driven pipeline more than doubled since the June 2026 Investor Day to more than $200 million. Management also noted a record number of proofs of concept as enterprises evaluate identity governance solutions for human and non-human identities.
SailPoint's SaaS Revenue Leads Subscription MixSaaS revenues jumped 34% year over year to $193.9 million. Maintenance and support revenues fell 8% to $35.5 million, while term subscription revenues declined 3% to $56.2 million. Other subscription services revenues increased 47% to $9.7 million.
Total subscription revenues advanced 19% to $295.2 million. Services and other revenues decreased 17% to $13.6 million, showing that subscription offerings remained the primary source of top-line growth.
The higher SaaS mix created an approximately $5 million revenue timing headwind in the quarter. SaaS revenues are recognized ratably, while a portion of term-license revenues is recognized upfront.
SailPoint Expands Customer and Contract BaseSaaS customer count increased 16% year over year, while ARR per SaaS customer rose 17% to more than $400,000. SailPoint ended the quarter with approximately 3,310 customers and had 235 customers generating more than $1 million in ARR, up 27% year over year.
Remaining performance obligations increased 30% to $1.9 billion. Current remaining performance obligations, representing amounts expected to be recognized as revenues over the next 12 months, advanced 27% to $931 million.
SAIL's Margins Hold Near Year-Ago LevelsAdjusted gross margin was 77.4%, down from 78.2% a year ago. Adjusted subscription gross margin was 82.3% compared with 83% in the prior-year quarter.
Adjusted research and development expenses rose 11.1% to $45 million. Adjusted sales and marketing expenses increased 19.5% to $111.3 million, while adjusted general and administrative expenses grew 4.5% to $20 million.
Adjusted income from operations increased 16.3% to $62.8 million, while adjusted operating margin was 20.3% versus 20.4% a year earlier.
SAIL's Cash Flow Moderates in Q2Cash and cash equivalents were $309.9 million as of July 31, 2026, compared with $358.1 million as of Jan. 31, 2026. Cash flows from operating activities were $45 million, down from $49.9 million in the year-ago quarter.
Free cash flow declined 18.6% to $37.4 million from $46 million, with free cash flow margin contracting to 12.1% from 17.4%. Investing outflows included $118.2 million for business acquisitions during the reported quarter.
SailPoint Raises ARR Outlook for Fiscal 2027For the fiscal third quarter, SailPoint expects ARR of $1.288-$1.292 billion, implying 24% year-over-year growth. Revenues are projected between $326 million and $330 million, with adjusted income from operations of $57.5-$58.5 million and adjusted earnings of 7-8 cents per share.
For fiscal 2027, the company raised its ARR outlook to $1.375-$1.385 billion from $1.364-$1.374 billion. Revenues remain forecast at $1.265-$1.275 billion, adjusted income from operations at $239-$244 million and adjusted earnings at 30-34 cents per share.
SailPoint continues to expect roughly $200 million in free cash flow.
How Have Estimates Been Moving Since Then?It turns out, fresh estimates have trended downward during the past month.
VGM ScoresCurrently, SailPoint, Inc. has a subpar Growth Score of D, however its Momentum Score is doing a lot better with an A. However, the stock has a grade of F on the value side, putting it in the bottom 20% quintile for value investors.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Interestingly, SailPoint, Inc. has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerSailPoint, Inc. belongs to the Zacks Internet - Software industry. Another stock from the same industry, Samsara Inc. (IOT - Free Report) , has gained 7.2% over the past month. More than a month has passed since the company reported results for the quarter ended July 2026.
Samsara Inc. reported revenues of $508.44 million in the last reported quarter, representing a year-over-year change of +29.9%. EPS of $0.20 for the same period compares with $0.12 a year ago.
Samsara Inc. is expected to post earnings of $0.19 per share for the current quarter, representing a year-over-year change of +26.7%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
Samsara Inc. has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of C.
Artemis Investment Management ve třetím čtvrtletí zvýšila svůj podíl ve společnosti Meta Platforms o 329,6 % na 192 252 akcií poté, co nakoupila dalších 147 497 akcií.
Artemis Investment Management LLP boosted its position in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 329.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 192,252 shares of the social networking company’s stock after purchasing an additional 147,497 shares during the quarter. Meta Platforms comprises about 1.1% of Artemis Investment Management LLP’s portfolio, making the stock its 26th biggest holding. Artemis Investment Management LLP’s holdings in Meta Platforms were worth $139,417,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Auto Owners Insurance Co raised its holdings in Meta Platforms by 76,587.7% during the 4th quarter. Auto Owners Insurance Co now owns 105,292,277 shares of the social networking company’s stock worth $69,502,379,000 after purchasing an additional 105,154,977 shares during the last quarter. State Street Corp grew its stake in Meta Platforms by 4.0% during the second quarter. State Street Corp now owns 92,033,963 shares of the social networking company’s stock worth $51,841,811,000 after purchasing an additional 3,510,123 shares during the period. Bank of America Corp DE grew its stake in Meta Platforms by 14.6% during the first quarter. Bank of America Corp DE now owns 21,038,035 shares of the social networking company’s stock worth $12,036,491,000 after purchasing an additional 2,673,494 shares during the period. Invesco Ltd. increased its holdings in Meta Platforms by 6.1% in the fourth quarter. Invesco Ltd. now owns 18,200,469 shares of the social networking company’s stock worth $12,013,948,000 after purchasing an additional 1,046,715 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Meta Platforms by 1.3% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,836,063 shares of the social networking company’s stock worth $7,230,426,000 after purchasing an additional 162,909 shares in the last quarter. 79.91% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Meta Platforms In other Meta Platforms news, insider Christopher Cox sold 40,000 shares of the stock in a transaction on Monday, September 21st. The shares were sold at an average price of $712.76, for a total transaction of $28,510,400.00. Following the completion of the sale, the insider owned 184,516 shares of the company’s stock, valued at $131,515,624.16. This represents a 17.82% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark Zuckerberg sold 27,474 shares of Meta Platforms stock in a transaction that occurred on Thursday, September 24th. The stock was sold at an average price of $777.44, for a total value of $21,359,386.56. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 148,222 shares of company stock worth $101,033,627 over the last three months. Company insiders own 13.53% of the company’s stock.
Key Headlines Impacting Meta Platforms Here are the key news stories impacting Meta Platforms this week: Positive Sentiment: Meta’s growing role in the micro-drama market could create a new advertising revenue stream. Short-form serialized shows are expanding beyond China, and the platform is becoming an important distribution channel for this content. Why Meta is winning the micro drama wars Positive Sentiment: Wells Fargo reportedly set a $1,000 price target, citing AI as a potential catalyst, while TD Cowen reaffirmed its “buy” rating with an $865 target. These targets imply analysts see substantial upside if Meta converts AI investment into higher engagement, advertising and commerce revenue. Meta Could Hit $1,000, Says Wells Fargo Positive Sentiment: Meta’s Muse assistant continues to expand, including a new iPad app, and the company is working with Sierra, Shopify, Stripe and Walmart on standards for AI agents to interact with businesses. Successful agentic commerce could eventually provide Meta with transaction-based revenue. Meta’s Muse launches on iPad Neutral Sentiment: President Donald Trump disclosed purchases of as much as $25 million in Meta stock, a headline that may support investor sentiment but does not change the company’s fundamentals. Trump bought up to $25 million in Meta Negative Sentiment: Jefferies found that roughly one-third of tested websites blocked Meta’s Muse agent. Access limitations could delay Meta’s plans to earn transaction fees from AI-powered shopping and other agentic-commerce services. Meta’s Muse AI agent blocked by websites Negative Sentiment: Florida is pursuing restrictions on Meta’s platforms, including a possible ban for users under 14 and limits on infinite scrolling for teenagers. Such rules could reduce engagement, advertising inventory and the effectiveness of Meta’s core products while increasing legal costs. Meta Stock Falls as Florida challenges infinite scroll Negative Sentiment: Investors remain concerned that Meta’s substantial AI data-center spending is consuming cash before returns are clear. Commentary also highlights criticism of CEO Mark Zuckerberg’s AI strategy and the risk that AI infrastructure becomes a prolonged cash-flow drag. Why AI Infrastructure Is Turning Meta and Amazon Into Cash-Flow Sinks Meta Platforms Trading Down 0.1% Shares of Meta Platforms stock opened at $720.89 on Friday. The stock has a market capitalization of $1.84 trillion, a P/E ratio of 27.15, a P/E/G ratio of 1.26 and a beta of 1.19. Meta Platforms, Inc. has a 52-week low of $520.26 and a 52-week high of $779.82. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.23 and a current ratio of 2.23. The stock’s 50-day simple moving average is $637.74 and its 200 day simple moving average is $619.40.
Meta Platforms (NASDAQ:META – Get Free Report) last posted its earnings results on Wednesday, July 29th. The social networking company reported $6.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($1.01). The firm had revenue of $60.80 billion during the quarter, compared to analysts’ expectations of $60.22 billion. Meta Platforms had a return on equity of 33.18% and a net margin of 29.83%.The business’s revenue for the quarter was up 28.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $7.14 earnings per share. As a group, research analysts anticipate that Meta Platforms, Inc. will post 27.94 EPS for the current year.
Meta Platforms Announces Dividend The firm also recently declared a quarterly dividend, which was paid on Monday, September 28th. Shareholders of record on Monday, September 21st were paid a $0.5250 dividend. The ex-dividend date of this dividend was Monday, September 21st. This represents a $2.10 annualized dividend and a yield of 0.3%. Meta Platforms’s payout ratio is currently 7.91%.
Wall Street Analysts Forecast Growth META has been the topic of several research reports. HSBC dropped their price objective on shares of Meta Platforms from $905.00 to $830.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. JPMorgan Chase & Co. boosted their target price on Meta Platforms from $820.00 to $920.00 and gave the company an “overweight” rating in a research report on Thursday, September 24th. Guggenheim reaffirmed a “buy” rating and set a $800.00 price target on shares of Meta Platforms in a research note on Tuesday, July 28th. Susquehanna cut their price target on Meta Platforms from $900.00 to $650.00 and set a “positive” rating on the stock in a report on Thursday, July 30th. Finally, UBS Group reissued an “overweight” rating on shares of Meta Platforms in a research note on Wednesday, September 23rd. Three research analysts have rated the stock with a Strong Buy rating, forty-four have assigned a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $791.86.
View Our Latest Research Report on Meta Platforms
About Meta Platforms (Free Report)
Meta Platforms, Inc is a technology company that develops social networking, messaging, virtual and augmented reality, and artificial intelligence products. The company operates a global family of apps that includes Facebook, Instagram, Messenger, WhatsApp and Threads, enabling users to connect, communicate, share content and discover communities.
Meta generates most of its business through digital advertising displayed across its platforms. Its products serve individuals, creators, businesses and organizations in markets around the world, while its advertising tools help businesses reach audiences based on factors such as interests, activity and demographics.
Through its Reality Labs division, Meta develops virtual and augmented reality hardware, software and services, including the Meta Quest line of headsets and related experiences.
See Also Five stocks we like better than Meta Platforms Want Private-Market Access to Kalshi and Polymarket? Try This ETF Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Meta Platforms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Meta Platforms and related companies with MarketBeat.com's FREE daily email newsletter.
Tesla vykázala záporný volný peněžní tok ve výši 1,09 mld. USD při letošním plánu kapitálových výdajů přesahujících 25 mld. USD; klíčový bude návrat volného peněžního toku do kladných hodnot a tržby ze služby Robotaxi.
Tesla is spending at a pace it has never attempted before, and earnings are falling while the bills pile up. Two specific conditions have to be met before this stock becomes a conviction buy, and right now neither one has…
Tesla (NASDAQ:TSLA | TSLA Price Prediction) trades at $375. Two developments would change the picture: free cash flow turns positive again, and Robotaxi starts producing revenue at scale. Tesla is now spending at a pace it has never tried before, and its earnings are falling while the spending ramps.
Tesla sells electric vehicles, grid batteries and Full Self-Driving (FSD) software. It is also building Robotaxi, Cybercab and the Optimus robot. Last quarter, revenue rose 25.52% to $28.24 billion and beat estimates. EPS of $0.33 missed expectations of $0.5367, and free cash flow fell to negative $1.09 billion.
Record Deliveries and a Cash Pile Power the Bull Case Demand is healthy. Deliveries hit a record 480,126, and Tesla ended the quarter with “our largest order backlog since 2023.” FSD subscriptions climbed 56% to 1.48 million. Services margin reached an all-time high of 14.1%, and energy storage deployments rose 41%.
Robotaxi now runs in seven U.S. metros. It has logged more than 380,000 miles of unsupervised driving with “zero notable incidents,” according to management. Tesla also holds $43.52 billion in cash. A forward P/E of 159, compared with a trailing P/E of 350, shows that analysts expect earnings to grow sharply.
A $25 Billion Spending Wave Is Squeezing Earnings Operating margin fell to 1.4% as operating expenses jumped 47%. Management expects capital spending this year to top $25 billion and to keep rising for two or three years. Tesla is also arranging debt facilities that would let it borrow up to $30 billion. Automotive gross margin excluding credits slipped to 16.3% from 19.2% the quarter before.
Some skeptics argue the stock is worth far less. Investor George Noble said “the cyber taxi thing is completely overcooked” and put his sum-of-the-parts value at $30 to $60 a share. Management expects the early Optimus ramp to be “quite flat and long.”
Robotaxi Miles Are Piling Up While Revenue Proof Lags The core business is working. Deliveries, FSD and services all grew. No one has yet shown how Robotaxi miles become profit. Management says unsupervised miles are growing more than 10% a week. Over the next two to four quarters, investors should watch for fleet revenue disclosures and signs that capital spending is paying for itself.
Down 16.61% This Year While the S&P 500 Gained 13.5% Tesla is down 16.61% year to date, while the S&P 500 is up 13.5%. Over one year, the stock is down 14.52%, while the index has gained 14.98%. The stock sits under its 200-day average of $392.19.
The consensus target of $392.42 implies upside. Here is how 43 analysts rate the stock:
Strong Buy: 4 Buy: 15 Hold: 20 Sell: 2 Strong Sell: 2 Cash Flow and Robotaxi Revenue Are the Two Tests That Matter Next At $375, Tesla faces two tests.
Free cash flow must turn positive and stay there for consecutive quarters, even with capital spending above $25 billion. If operating margin climbs from 1.4%, the spending is paying off.
Robotaxi must report real fleet revenue, with Cybercab moving from pilot builds to volume production. Unsupervised miles prove the technology works; revenue proves the business model works.
A Robotaxi breakthrough could lift the stock quickly. The valuation also carries risk: Tesla still trades at 350 times trailing earnings while its cash flow is negative (riding a story stock at that multiple is fine as long as you plan the exit, something our free bubble survivor’s handbook walks through in detail). If both conditions are met, the investment case strengthens. If cash burn grows with no fleet revenue, it weakens.
The vision is fully priced in, and the proof has not arrived yet.
Contact [email protected] for any questions or corrections.
Tesla na svých evropských webových stránkách přejmenovala funkci Full Self-Driving na Tesla Assisted Driving poté, co regulátoři označili původní název za zavádějící.
SummaryCompaniesTesla rebrands FSD as 'Tesla Assisted Driving' on European websitesGermany said Tuesday Tesla offered the name changeRegulators have called the 'Full Self-Driving' name misleadingOct 9 (Reuters) - EV-maker Tesla (TSLA.O), opens new tab has started calling its "Full Self-Driving" feature "Tesla Assisted Driving" on its European websites, dropping a name regulators have said was misleading, as CEO Elon Musk pushes for EU-wide approval for the software.
The rebrand comes after Germany said on Tuesday Tesla had offered to switch to the new name. Musk has described the self-driving technology as key to the company's future growth.
Sign up here.
Tesla's FSD page for Slovakia now redirects to a "Tesla Assisted Driving" page, as do pages in other European countries such as Germany, Spain and the Netherlands. The US site still refers to it as "Full Self-Driving (Supervised)."
A Reuters report published this week detailed how Tesla mounted a campaign to win approval for FSD in Europe, including encouraging owners and supporters to lobby national regulators for faster approvals.
In September, a Norwegian Tesla owner asked the Norwegian Public Roads Administration whether Tesla's changes to how it described FSD addressed concerns about the name, according to documents Reuters obtained through freedom-of-information requests.
"Please do not simply say again that 'we are waiting for the EU' without explaining what Tesla or Norway must deliver in the meantime," the owner said.
Several regulators have said the old name is misleading because the system requires constant supervision and drivers remain legally responsible.
In Sweden, consumer protection authorities had earlier asked the Swedish Transport Agency to assess whether the marketing of FSD could give buyers the false impression the system was capable of fully autonomous driving.
In Italy, authorities had said in internal government correspondence that the name "Full Self-Driving", together with Tesla's promotional material, "could lead users to believe that the vehicle is equipped with unsupervised automatic driving functions attributable to higher levels of automation, particularly SAE Level 3", in communication seen by Reuters through freedom-of-information requests.
Eight EU countries already allow the system, with Slovakia expecting to become the ninth within days.
An EU-wide vote has been pushed from October to at least December, with countries like France conducting additional testing.
Reporting by Prathik Jayaprakash in Bengaluru and Marie Mannes in Stockholm; Editing by Pooja Desai
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Tesla uvádí, že její vozy Robotaxi ujely celkem 2,5 milionu placených mil; škálování služby a její ziskovost budou klíčové pro cílovou cenu 500 USD analytika Dana Ivese.
Tesla Inc‘s (NASDAQ:TSLA) next valuation test may have less to do with how many electric vehicles it sells and more to do with how much money it can make from the cars already on the road.
Yorkville Ives analyst Dan Ives sees autonomy and robotics reshaping Tesla’s future, but turning that vision into recurring revenue is what could determine whether his $500 price target holds up.
The $500 Case Goes Beyond EVsIn his latest research note, Ives maintains an Outperform rating and a $500 price target, arguing that Tesla is evolving into a "physical AI" platform spanning vehicles, autonomous driving, humanoid robots and energy storage. He says investors who value Tesla primarily as an automaker risk overlooking the software and services that could eventually generate revenue on top of its existing vehicle business.
The foundation is Tesla’s fleet of millions of vehicles, which generates real-world driving data to train its Full Self-Driving (FSD) system. Unlike companies building autonomous technology without a comparable installed vehicle base, Tesla can connect data collection, software development and vehicle manufacturing within one ecosystem.
But the opportunity depends on monetization, not just technology. As Tesla’s latest shareholder update shows, FSD adoption is growing, with more than 55% of new North American deliveries including FSD subscriptions in the reported quarter. That creates a software revenue stream today while building the technical foundation for a larger autonomous-driving business.
Read Next
Robotaxi Is the Real TestIves sees Robotaxi as the bridge between Tesla’s current automotive business and its potential autonomy-driven future. Tesla reported about 2.5 million cumulative paid Robotaxi miles in its latest quarterly update, while expanding operations and preparing to deploy its purpose-built Cybercab.
The distinction between paid miles and a profitable business remains important. More rides can demonstrate demand and help Tesla gather driving data, but investors still need evidence of fleet utilization, operating costs and revenue per vehicle. Scaling unsupervised operations across more cities would also require regulatory progress and consistent safety performance.
Cybercab could improve the economics by removing conventional driving controls and designing the vehicle specifically for autonomous service. Yet production capacity, including the availability of 4680 battery packs cited in Ives’ note, could constrain how quickly Tesla expands its fleet.
What Investors Should WatchIves also sees Tesla’s Optimus robots and energy-storage business expanding the company’s addressable markets. Those opportunities could strengthen the $500 case, but they also require investment before their contribution to earnings becomes clear.
Tesla’s next test is whether it can scale Robotaxi operations while preserving the cash-generating power of its vehicle business. Investors should watch fleet growth, paid miles, FSD subscriptions and Cybercab production for evidence that physical AI is becoming a measurable business rather than a valuation promise.
TSLA Price Action: Tesla shares were up 3.15% at $386.80 at the time of publication on Friday, according to Benzinga Pro data.
Akcie Coca-Cola (KO) letos vzrostly o 30,9 %, což vyvolává obavy z nadhodnocení navzdory vysokým maržím a růstovému potenciálu na rozvíjejících se trzích.
SummaryThe Coca-Cola Company earns a buy rating, supported by a robust economic moat, premium margins, and unrivaled brand equity.KO's asset-light model, high-margin concentrate sales, and long-term bottler contracts drive sector-leading profitability and efficiency.Emerging markets, especially Asia Pacific, offer significant growth runway, with KO outpacing regional market expansion and gaining share.Valuation concerns exist, but KO's superior margins, earnings growth, and dividend track record justify its premium relative to peers. Mindstyle/iStock Editorial via Getty Images
Introduction The Coca-Cola Company (KO) stock has enjoyed a strong year, with a 30.9% rise. However, this has also sparked concerns about overvaluation, as it now trades at a forward price-to-earnings (P/E) ratio of
97 Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of KO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Microsoft ve čtvrtletí vykázal tržby ve výši 90,01 miliardy USD, což představuje meziroční nárůst o 17,7 %, a zisk na jednu akcii 4,74 USD, oproti odhadu 4,24 USD.
Investor s Fiduciary Advisor Network LLC cut its stake in Microsoft Corporation (NASDAQ:MSFT – Free Report) by 6.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,040 shares of the software giant’s stock after selling 2,354 shares during the period. Microsoft makes up about 4.1% of Investor s Fiduciary Advisor Network LLC’s portfolio, making the stock its 3rd biggest holding. Investor s Fiduciary Advisor Network LLC’s holdings in Microsoft were worth $11,951,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently modified their holdings of MSFT. Auto Owners Insurance Co grew its stake in Microsoft by 56,160.8% during the fourth quarter. Auto Owners Insurance Co now owns 60,116,384 shares of the software giant’s stock worth $29,073,486,000 after buying an additional 60,009,531 shares in the last quarter. Bank of America Corp DE bought a new position in Microsoft in the 2nd quarter valued at about $27,338,370,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Microsoft by 0.9% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 64,375,360 shares of the software giant’s stock valued at $24,013,297,000 after buying an additional 543,172 shares in the last quarter. Legal & General Group Plc acquired a new position in shares of Microsoft in the 2nd quarter valued at approximately $18,306,443,000. Finally, Amundi lifted its holdings in shares of Microsoft by 30.8% during the 1st quarter. Amundi now owns 41,675,076 shares of the software giant’s stock worth $15,426,862,000 after acquiring an additional 9,814,598 shares during the period. 71.13% of the stock is currently owned by institutional investors.
Microsoft Stock Down 1.3% Shares of MSFT opened at $522.61 on Friday. The stock’s 50-day moving average price is $499.74 and its two-hundred day moving average price is $434.03. Microsoft Corporation has a 12 month low of $349.20 and a 12 month high of $553.72. The company has a market capitalization of $3.88 trillion, a PE ratio of 29.10, a PEG ratio of 1.70 and a beta of 1.10. The company has a current ratio of 1.23, a quick ratio of 1.22 and a debt-to-equity ratio of 0.07.
Microsoft (NASDAQ:MSFT – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The software giant reported $4.74 earnings per share for the quarter, beating the consensus estimate of $4.24 by $0.50. Microsoft had a return on equity of 31.98% and a net margin of 40.31%.The company had revenue of $90.01 billion during the quarter, compared to analysts’ expectations of $87.62 billion. During the same quarter in the prior year, the firm posted $3.65 earnings per share. The business’s quarterly revenue was up 17.7% on a year-over-year basis. On average, analysts anticipate that Microsoft Corporation will post 19.65 EPS for the current year. Microsoft Increases Dividend The company also recently declared a quarterly dividend, which will be paid on Thursday, December 10th. Stockholders of record on Thursday, November 19th will be given a $0.98 dividend. This is an increase from Microsoft’s previous quarterly dividend of $0.91. The ex-dividend date is Thursday, November 19th. This represents a $3.92 dividend on an annualized basis and a dividend yield of 0.8%. Microsoft’s dividend payout ratio is presently 20.27%.
Insider Activity In related news, EVP Takeshi Numoto sold 4,810 shares of the company’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $496.48, for a total transaction of $2,388,068.80. Following the sale, the executive vice president owned 42,677 shares in the company, valued at $21,188,276.96. This represents a 10.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Judson Althoff sold 10,000 shares of the stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $487.89, for a total value of $4,878,900.00. Following the transaction, the chief executive officer owned 100,447 shares in the company, valued at $49,007,086.83. The trade was a 9.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 143,009 shares of company stock valued at $71,420,699. Company insiders own 0.03% of the company’s stock.
More Microsoft News Here are the key news stories impacting Microsoft this week:
Positive Sentiment: Microsoft expanded its AI relationship with Nvidia and introduced the $2,599 Surface Laptop Ultra, powered by Nvidia’s RTX technology. The device is designed to run AI models and agents locally, potentially strengthening Windows’ role in the emerging “agentic” PC market. Is Microsoft Stock a Buy After Expanding Its Nvidia Partnership? Positive Sentiment: Analysts continue to cite Azure momentum, Copilot demand and Microsoft’s large backlog as evidence that its more than $175 billion AI infrastructure investment could generate sustainable returns. Morgan Stanley reaffirmed a Buy rating with a $600 price target, while other analysts have issued targets as high as $635. Microsoft’s Integrated AI Stack and Enterprise Copilot Flywheel Justify Buy Rating Neutral Sentiment: Microsoft announced that fiscal 2027 first-quarter results will be released after the market closes on October 28. Investors are likely to focus on Azure growth, Copilot adoption, AI capital expenditures, free cash flow and forward guidance. Microsoft Announces Quarterly Earnings Release Date Negative Sentiment: The Labor Department suspended Microsoft from the Permanent Labor Certification program used to help foreign workers obtain U.S. permanent residency, alleging misuse of worker programs. The restriction could raise hiring costs and, over time, make it harder to retain specialized AI talent, although the near-term earnings impact is expected to be limited. U.S. Suspends Microsoft, Adobe From Green-Card Labor Program Negative Sentiment: Investors are increasingly concerned that Microsoft’s valuation is less attractive after its strong run, while heavy AI data-center spending may pressure free cash flow. Reports also questioned the reliability of OpenAI’s annual recurring revenue figures, adding uncertainty around a key AI partner. Oracle, Microsoft Shares Decline as OpenAI’s ARR Is Questioned Negative Sentiment: Italy launched an EU-backed antitrust investigation into Microsoft-owned gaming companies over their use of virtual currencies, creating an additional regulatory overhang for the Xbox business. Italy Launches EU-Backed Probe Into Microsoft-Owned Gaming Companies Wall Street Analysts Forecast Growth A number of equities research analysts have weighed in on MSFT shares. Guggenheim reaffirmed a “buy” rating and issued a $586.00 target price on shares of Microsoft in a report on Monday, July 27th. Mizuho reduced their price target on shares of Microsoft from $515.00 to $490.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 15th. Argus lowered their price objective on shares of Microsoft from $620.00 to $510.00 and set a “buy” rating for the company in a research report on Friday, July 10th. Royal Bank Of Canada reissued an “outperform” rating on shares of Microsoft in a research note on Thursday, September 10th. Finally, Morgan Stanley lowered shares of Microsoft from an “overweight” rating to a “negative” rating in a research report on Monday. Forty-one equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $578.73.
Get Our Latest Research Report on Microsoft
Microsoft Profile (Free Report)
Microsoft Corporation is a global technology company that develops software, cloud services, devices, gaming products and business solutions. Founded in 1975 by Bill Gates and Paul Allen, the company is best known for the Windows operating system and Microsoft Office productivity software. Microsoft is headquartered in Redmond, Washington, and serves consumers, businesses, governments and educational institutions worldwide.
Microsoft’s productivity and business offerings include Microsoft 365 applications such as Word, Excel, PowerPoint and Outlook, along with collaboration tools including Teams.
Featured Articles Five stocks we like better than Microsoft Want Private-Market Access to Kalshi and Polymarket? Try This ETF Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
Microsoft Corporation NASDAQ: MSFT stock is closing in on familiar territory. Shares traded around $530 this week. That puts MSFT within 5% of its 52-week high of $553.72.
Microsoft Today
$534.94 +12.33 (+2.36%)
As of 12:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.
$349.20▼
$553.720.73%
29.78
$578.73
That's a remarkable turnaround. Microsoft gained about 37% in the third quarter of 2026. It was the company's best quarterly performance since 1998. In late June, shares were trading around $372.
Get Microsoft alerts:
But the easy part of this rally may be over. The next leg is less about Microsoft's business and more about investor psychology.
MSFT peaked near $555 in October 2025. It then spent roughly eight months falling. At the bottom, a $10,000 investment made at the peak was worth about $6,510. Many of those investors are finally close to breaking even.
That creates a different kind of test for MSFT stock. Investors tend to sell winners too early and hold losers too long. When a losing position finally gets back to even, the urge to sell can be overwhelming.
Microsoft's fundamentals have earned this rally. Now the stock has to work through a wall of breakeven sellers. And it has to do that heading into an earnings report where expectations are much higher than they were three months ago.
Q4 Turned a Pariah Into Wall Street's DarlingIt's hard to overstate how fast the narrative changed. Heading into July, the story around Microsoft was capital expenditures (CapEx) fatigue. Investors questioned whether its massive AI spending would ever earn an adequate return.
Then Microsoft reported fiscal fourth-quarter 2026 results on July 29. Revenue came in at $90 billion, up nearly 18% year-over-year. Azure crossed $100 billion in annual revenue for the first time. Earnings per share (EPS) of $4.74 topped the $4.24 consensus estimate.
The stock jumped about 15% the next day. It was Microsoft's biggest single-day gain since 2008.
Analysts have followed the price higher. Stifel upgraded MSFT to Buy in late September. On Oct. 5, Melius Research upgraded the stock to Buy with a $665 price target. Scotiabank raised its target to $615 from $510.
This is the same company, with largely the same AI strategy, that investors were avoiding in the spring. What changed was perception. In other words, the numbers gave investors permission to believe again.
Why $555 Is a Psychological Level, Not Just a Technical OneMost investors will see $553.72 as resistance on a chart. That's true, but it misses the behavioral story behind the number.
Think about who owns MSFT at that level. Many bought during the AI enthusiasm of late 2025. Some added on the way down, convinced the sell-off was overdone. Others simply held through a drawdown of roughly 35%.
Behavioral economists call the tendency to sell winners and hold losers the disposition effect. A related bias, sometimes called "get-evenitis," keeps investors anchored to their purchase price. Once a stock gets back there, the relief of not losing money often beats the hope of more gains.
That doesn't mean Microsoft can't break through. It means the stock needs a reason to absorb that supply. Momentum alone may not be enough. A fresh catalyst usually does the job. For Microsoft, that catalyst is its Q1 earnings report for fiscal year 2027 (FY2027).
Earnings Will Have to Clear a Higher BarMicrosoft hasn't confirmed its next earnings date, but the report date is estimated for Oct. 28. The headline number will be Azure growth. Management guided for growth of about 45% in the quarter.
Three months ago, a number like that would have looked like upside. Now it's closer to the baseline. With the stock up nearly 40% in a quarter, investors may want more than a match.
There's also some fine print in last quarter's beat. The $4.74 EPS figure included a $3.2 billion gain on Microsoft's Anthropic stake. That's a real gain, but it isn't a repeatable operating result.
Spending remains part of the debate, too. Quarterly capital expenditures roughly doubled year-over-year, and free cash flow fell about 23%. Management also expects CapEx to grow again in fiscal 2027.
None of this breaks the bull case. CFO Amy Hood said in July that demand still exceeds available capacity. But it does mean the stock has less room for a merely good quarter.
Chasing MSFT at $530 Is a Different TradeFor long-term investors, Microsoft's story looks stronger than it did six months ago. Its AI investments are showing up in revenue, and Wall Street sentiment has turned firmly bullish.
But buying MSFT at $530 isn't the same trade as buying it at $372. At roughly 30x trailing earnings, the stock is priced for steady execution. The margin for error is thinner.
Investors who want exposure may be better served by scaling in. A pullback toward $500, where the stock consolidated in late September, would offer a more comfortable entry. A decisive close above $553.72 on strong volume would confirm a breakout.
If MSFT stalls near its old high, don't read it as a verdict on the business. It may simply be breakeven investors heading for the exits. Once they're gone, the path higher could get a lot easier.
Should You Invest $1,000 in Microsoft Right Now?Before you consider Microsoft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microsoft wasn't on the list.
While Microsoft currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Analytici očekávají, že Bank of America za čtvrtletí vykáže zisk 1,11 USD na akcii a tržby ve výši 30,62 miliardy USD, což by představovalo meziroční nárůst o 4,7 %, respektive o 9 %.
Analysts on Wall Street project that Bank of America (BAC - Free Report) will announce quarterly earnings of $1.11 per share in its forthcoming report, representing an increase of 4.7% year over year. Revenues are projected to reach $30.62 billion, increasing 9% from the same quarter last year.
The current level reflects a downward revision of 0.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Bank of America metrics that are commonly monitored and projected by Wall Street analysts.
The consensus estimate for 'Efficiency Ratio (FTE basis)' stands at 59.8%. Compared to the current estimate, the company reported 61.4% in the same quarter of the previous year.
The consensus among analysts is that 'Total earning assets - Average balance' will reach $3112.61 billion. The estimate is in contrast to the year-ago figure of $3040.19 billion.
Analysts predict that the 'Book value per share of common stock' will reach $39.68 . Compared to the present estimate, the company reported $37.95 in the same quarter last year.
The average prediction of analysts places 'Total nonperforming loans and leases' at $6.46 billion. Compared to the present estimate, the company reported $5.35 billion in the same quarter last year.
Analysts forecast 'Tier 1 Capital Ratio' to reach 12.4%. Compared to the present estimate, the company reported 13.1% in the same quarter last year.
Based on the collective assessment of analysts, 'Total nonperforming loans, leases and foreclosed properties' should arrive at $6.58 billion. Compared to the present estimate, the company reported $5.47 billion in the same quarter last year.
Analysts' assessment points toward 'Tier 1 Leverage Ratio' reaching 6.5%. Compared to the present estimate, the company reported 6.8% in the same quarter last year.
The collective assessment of analysts points to an estimated 'Net Interest Income- Fully taxable-equivalent basis' of $16.55 billion. Compared to the present estimate, the company reported $15.39 billion in the same quarter last year.
According to the collective judgment of analysts, 'Total Noninterest Income' should come in at $14.32 billion. The estimate is in contrast to the year-ago figure of $12.86 billion.
The combined assessment of analysts suggests that 'Investment and brokerage services' will likely reach $5.86 billion. The estimate is in contrast to the year-ago figure of $5.06 billion.
It is projected by analysts that the 'Investment banking fees' will reach $1.71 billion. The estimate compares to the year-ago value of $2.01 billion.
Analysts expect 'Total fees and commissions' to come in at $11.00 billion. The estimate is in contrast to the year-ago figure of $10.34 billion.
View all Key Company Metrics for Bank of America here>>>
Bank of America shares have witnessed a change of -14.3% in the past month, in contrast to the Zacks S&P 500 composite's +1.3% move. With a Zacks Rank #3 (Hold), BAC is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
While the S&P 500 soared and rival GM recovered, Ford kept finding new ways to stumble under CEO Jim Farley, and the reasons behind its five-year slide reveal a company struggling to hold its ground in almost every market it…
Ford’s (NYSE: F | F Price Prediction) stock is down 18% over the last five years, while the S&P 500 is up 75%. Ford argues that its dividend makes up some of the difference. Investors in the stock itself have not bought into that story. Rival GM’s (NYSE: GM) stock is up 40% over the period. Ford has done little over the last half-decade to help the stock, unless the “little” is a series of unforced errors.
CEO Jim Farley has held the top job for six years, so almost all of the drop has come on his watch.
Ford held a strong position in the US fossil-fuel car industry. Most of it came from its SUV and pickup products. The F-Series full-size pickup has been America’s top-selling vehicle for over four decades. It is 37% of Ford’s US sales today. Ford hasn’t been able to change that, which makes it something of a one-legged stool in its home market.
Ford’s China and Europe businesses were once solid. That is not the case anymore. Ford’s sales in Europe were down 17.7% for the first eight months to 171,670. That puts it behind Chinese EV company BYD, which grew by 163% to 177,752.
CNBC recently reported, “Ford’s own language for what’s happening is more revealing than any outside description could be. The company describes its China unit’s strategy as building ‘in China, for the world.’” In other words, Ford sales in China are poor.
Among the world’s three largest car markets, it is only doing well in one–the US. And Ford barely held on to third place in third-quarter unit sales. It barely edged out South Korea’s Hyundai Motor.
Ford’s move in and out of EVs has been so well covered by the press that it is not worth mentioning.
Finally, Ford’s new move into EVs is a small, inexpensive pickup. The Fathom goes on sale a year from now. It is more evidence that Ford cannot turn on a dime to get models out the door. The Fathom is built on Ford’s unproven Universal EV Production System.
Ford’s stock has had a horrible five years. Nothing on the horizon suggests that will change.
Contact [email protected] for any questions or corrections.
Společnost SpaceX se dohodla na akvizici licencí v pásmu 800 MHz od společnosti Grain Management, aby posílila Starlink Mobile. Transakce vyžaduje schválení FCC.
Space Exploration Technologies Corp.‘s (NASDAQ:SPCX) push into wireless is creating an unexpected split in the stock market: traditional telecom carriers are under pressure, while the companies that own their physical infrastructure are climbing.
The distinction matters because even a satellite-powered mobile network may need plenty of equipment on the ground, potentially turning a threat to Verizon Communications Inc. (NYSE:VZ) into an opportunity for cell-tower owners.
SpaceX Raises the StakesOn Oct. 8, SpaceX agreed to acquire Grain Management’s nationwide portfolio of 800 MHz wireless spectrum licenses, a move designed to help Starlink Mobile become a major U.S. carrier. The deal covers up to 14 megahertz of paired spectrum and requires approval from the Federal Communications Commission, according to Grain Management’s announcement.
The market wasted little time reacting. Verizon, AT&T Inc. (NYSE:T) and T-Mobile Inc (NASDAQ:TMUS) fell between 5.5% and 7.4% in premarket trading on Oct. 9, while SpaceX shares rose. The sell-off reflected investor concerns that Starlink could eventually compete for wireless subscribers, particularly in rural markets where satellite connectivity has an advantage.
Low-band spectrum can travel farther and penetrate buildings more effectively than higher-frequency signals. Combined with satellites, it could help SpaceX extend connectivity beyond traditional coverage gaps and challenge established carriers’ pricing and customer relationships.
Read Next
Why Tower Stocks Are RisingThe surprising beneficiaries are American Tower Corp. (REIT) (NYSE:AMT), Crown Castle Inc. (NYSE:CCI) and SBA Communications Corp (NASDAQ:SBAC). Their shares rose as investors considered a possibility that the carrier sell-off obscures: SpaceX may disrupt wireless service without eliminating the need for terrestrial infrastructure.
Satellites can provide broad coverage, but ground-based networks remain important for capacity in densely populated areas. Towers, rooftops and small-cell equipment can help connect devices and manage traffic where demand is concentrated.
Reuters cited Morgan Stanley analysts describing the spectrum transaction as potentially constructive for tower operators. A hybrid network could require additional ground deployments, particularly if SpaceX competes beyond rural coverage and targets urban subscribers.
That is an opportunity, not a guaranteed windfall. Tower companies would benefit only if SpaceX or its partners actually lease infrastructure or deploy equipment that generates additional revenue. The acquisition alone does not establish that contracts are coming.
What Investors Should WatchThe next catalyst is execution. Investors should look for FCC approval, details of Starlink Mobile’s rollout and evidence of tower-leasing agreements that could translate the market’s optimism into revenue. Verizon and its peers face a potential new competitor, but the threat will depend on coverage, pricing and how quickly SpaceX can build a reliable service.
For tower owners, the investment case is more nuanced than simply betting against telecom carriers. If SpaceX expands its terrestrial network, infrastructure providers could gain a new customer even as existing tenants face competitive pressure. Until leasing commitments emerge, however, the rally remains a bet on what SpaceX may need — not revenue it has already secured.
Key Takeaways BlackRock is set to report Q3 earnings on Oct. 14, with EPS expected to rise 21.6% y/y.BLK's AUM is expected to jump 16.4% y/y, driven by market appreciation and healthy inflows.BlackRock's revenues are expected to grow 14.5% y/y despite rising costs and fee pressure. BlackRock (BLK - Free Report) is slated to report third-quarter 2026 results on Oct. 14, before the opening bell. Its quarterly revenues and earnings are expected to have improved year over year.
BLK’s second-quarter 2026 adjusted earnings surpassed the Zacks Consensus Estimate. Results benefited from a rise in revenues. The assets under management (AUM) balance witnessed growth to record levels, driven mainly by net inflows and AUM additions from the HPS and ElmTree transactions. However, higher expenses created a headwind.
BlackRock has an impressive earnings surprise history. Its earnings surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 7.3%.
Before we take a look at what our quantitative model predicts for the to-be-reported quarter, let us check the factors that are likely to have impacted BlackRock’s performance.
Key Factors & Q3 Estimates for BLKAUM: BlackRock’s AUM is expected to have benefited from equity market appreciation during the third quarter, supported by continued investor interest in artificial intelligence (AI)-related companies and relatively resilient global equity markets. However, intermittent market volatility and uncertainties surrounding interest rates and geopolitical developments may have moderated gains in certain asset classes.
The company’s industry-leading iShares exchange-traded fund (ETF) franchise is likely to have continued attracting healthy inflows, supported by sustained investor demand for low-cost, diversified investment products. Continued demand for fixed-income ETFs, active investment strategies and cash-management solutions is also expected to have supported organic AUM growth.
Additionally, BlackRock’s expanding private-markets platform may have contributed to asset growth, although the timing of institutional allocations and fundraising activity could have influenced quarterly flows.
Nevertheless, fluctuations in foreign-exchange rates, market volatility and institutional portfolio rebalancing may have affected overall AUM growth to some extent.
The Zacks Consensus Estimate for BLK’s total AUM for the third quarter is pegged at $15.67 trillion, indicating a year-over-year jump of 16.4%.
Revenue Components: BlackRock is expected to have recorded growth in its investment advisory, administration fees and securities-lending revenues on decent inflows and latest offerings. The consensus estimate for the metric is $6.02 billion, implying a 19.2% year-over-year rise.
The consensus estimate for distribution fees of $415 million indicates a year-over-year rise of 16.9%. The consensus estimate for technology services revenues is pegged at $583 million, implying a 13.2% rally.
The Zacks Consensus Estimate for advisory and other revenues is pegged at $85 million, which indicates a year-over-year rise of 10.4%.
However, the Zacks Consensus Estimate for investment advisory performance fees is pegged at $412 million, suggesting a 20.2% year-over-year decline.
Expenses: BlackRock’s expenses have been elevated over the past few years. Overall costs are expected to have increased in the third quarter, given that the company has been continuing its restructuring initiatives to modify the size and shape of its workforce and improve operating efficiency. Also, its inorganic expansion efforts are likely to have increased expenses.
What Our Model Unveils for BlackRockAccording to our quantitative model, the chances of BLK beating the Zacks Consensus Estimate for earnings this time are low. This is because it does not have the right combination of the two key ingredients — a positive Earnings ESP and a Zacks Rank #3 (Hold) or better.
You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Earnings ESP: The Earnings ESP for BlackRock is -0.45%.
Zacks Rank: The company currently carries a Zacks Rank #3.
The Zacks Consensus Estimate for BLK’s third-quarter earnings of $14.04 per share has been revised lower over the past seven days. The estimate indicates a 21.6% increase from the year-ago quarter’s reported number.
The consensus estimate for quarterly sales is pegged at $7.45 billion, which suggests a year-over-year rise of 14.5%.
Finance Stocks Worth a LookHere are a couple of finance stocks, which, per our model, have the right combination of elements to post an earnings beat in their upcoming releases:
State Street (STT - Free Report) is scheduled to announce third-quarter 2026 results on Oct. 14. The company has a Zacks Rank #3 and an Earnings ESP of +0.58% at present.
Quarterly earnings estimates for State Street have been revised upward to $3.64 over the past week.
The Earnings ESP for Prosperity Bancshares, Inc. (PB - Free Report) is +0.22% and it carries a Zacks Rank #3 at present. The company is slated to report third-quarter 2026 results on Oct. 28. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Over the past seven days, the Zacks Consensus Estimate for PB’s quarterly earnings has been revised lower to $1.63 per share.
Starbucks once seemed unstoppable, expanding from 16,000 stores to 38,000 in just six years, yet something quietly broke along the way. A new CEO, a reshaped menu, and a bold bet in China have done little to convince shareholders that…
For years, Starbucks (NASDAQ: SBUX) was a growth company and a growth stock. In 2016, it had about 16,000 stores, including company-owned and franchised locations. By 2022, it had reached 38,000 stores, and that growth began to flatten. Investors started to beat down its shares at the same time. Comparable sales, which also suffered, have begun to grow after a period of decline. That has not been enough. Shares are down 16% over the last five years. The S&P 500 is 75% higher. Could it be worse? Sure, but not by much.
What are investors seeing? Growth stopped. One problem was revenue. The other was comparable store sales. However, in the most recent quarter, comparable store sales rose 7.9%. But revenue was flat at $9.3 billion. It showed progress and was enough to give the stock a bump, but it was not sustainable.
And Starbucks abandoned its primary global growth initiative. Boyu Capital in China took a 60% stake. Starbucks kept 40% and “continues to own and license the brand and intellectual property to the joint venture.” The venture set a goal of reaching 20,000 stores from the current 8,000. However, what evidence is there that a new controlling shareholder can do that? Local coffee store leader Luckin’ Coffee has 35,000 stores worldwide, most of which are in China.
Some hoped new CEO Brian Niccol could carry over success from his last job at Chipotle (NYSE: CMG). He began by closing underperforming Starbucks locations, setting a dress code for local store staff, making modest personnel cuts, removing low-performing items from the menu, and reducing customer wait times. Shareholders viewed this as window dressing. The stock is down 10% in the last month.
How many investors believe Starbucks can end its five-year stock slide? Not many.
Contact [email protected] for any questions or corrections.
Společnost Shopify ve druhém čtvrtletí meziročně zvýšila čistý zisk na akcii o 68 % na 1,16 USD, zatímco její tržby vzrostly o 34 % na 3,6 miliardy USD.
Shopify (SHOP +2.56%) stock has seen some volatile swings over the last five years. While the company's share price has been surging recently, it's still only up roughly 22% over the last half decade. Meanwhile, the S&P 500 is up 79%, and the Nasdaq Composite has risen 90%.
But while the e-commerce services specialist's share price gains have lagged behind the broader market over that stretch, the fact that the company's net income per share increased 68% year over year in the second quarter to reach $1.16 is hard to ignore.
Image source: Getty Images.
Trading at roughly 67 times next year's expected earnings, Shopify undeniably has a growth-dependent valuation -- but recent momentum for earnings expansion has looked very encouraging. Crucially, the foundations needed to keep earnings growing at a strong clip appear to be in place.
Gross merchandise volume across Shopify's e-commerce platform increased 32% year over year to reach roughly $116 billion in the second quarter. In turn, this helped push revenue for the period up 34% year over year to $3.6 billion.
Premium Feature
Moneyball Superscore
88/100
Today's Change
(
2.56
%) $
4.22
Current Price
$
168.78
Demand for the company's e-commerce services continues to look very strong, and Shopify should continue benefiting from new merchants joining its platform and scaling their operations. The company may also be in the early stages of benefiting from cost-cutting efficiencies and engagement tailwinds connected to artificial intelligence that can further support strong earnings growth.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Shopify. The Motley Fool has a disclosure policy.
Cisco uzavřelo fiskální rok 2026 s objednávkami AI infrastruktury od hyperscalerů za 9,3 mld. USD a pro fiskální rok 2027 očekává související tržby ve výši 7,5 mld. USD.
Key Takeaways Cisco Systems closed fiscal 2026 with $9.3 billion in hyperscaler AI infrastructure orders.Hyperscaler AI revenues are expected to reach $7.5 billion in fiscal 2027, up from $4 billion.Networking product orders rose 40% year over year in the fourth quarter of fiscal 2026. Cisco Systems Inc. (CSCO - Free Report) has been benefiting from strong product orders from hyperscalers, enterprises, service providers, the public sector and cloud customers. In fiscal 2026, CSCO generated record-high revenues primarily due to its networking portfolio, powered by Silicon One, AI-native security solutions and operating systems. Increasing AI workloads at the network edge and the emergence of physical AI are benefiting the industrial IoT portfolio.
The chart below shows the price performance of CSCO year to date.
Image Source: Zacks Investment Research
CSCO Rides on AI Networking StrengthCisco closed fiscal 2026 with $9.3 billion in hyperscaler AI infrastructure orders, about 4.5 times fiscal 2025, and roughly $4 billion in related revenues. CSCO expects hyperscaler AI revenues to reach $7.5 billion in fiscal 2027. In the fourth quarter of fiscal 2026, networking product orders rose 40% year over year, the eighth straight quarter of double-digit growth.
Company-wide orders excluding hyperscalers rose 25% in the fourth quarter of fiscal 2026. CSCO links this demand to AI traffic, infrastructure modernization and security requirements, reinforcing its view of a multi-year networking cycle.
AI hyperscaler behemoths like Amazon.com Inc. (AMZN - Free Report) , Microsoft Corp. (MSFT - Free Report) , Meta Platforms Inc. (META - Free Report) and Alphabet Inc. (GOOGL - Free Report) are using CSCO’s AI-enabled networking infrastructure and switching equipment for their data centers.
Silicon & Optics PositioningCisco’s vertically integrated networking stack is expanding across scale-out and scale-across AI architectures. In the fourth quarter of fiscal 2026, the company won three new hyperscaler designs, covering a P200 scale-across system, a G200 scale-out system and an optical line system. Fiscal 2026 hyperscaler AI orders were about 60% Silicon One-based systems and 40% optics, while Acacia generated more than $1 billion in orders in the last reported quarter.
Security and Collaboration BusinessIn the fourth quarter of fiscal 2026, security revenues increased 14% year over year. More than 1,500 customers bought newer security products, while firewall orders grew more than 30% for the second consecutive quarter. CSCO expects security growth to move from low single digits in fiscal 2026 to high single digits in fiscal 2027 and reach double-digit growth as the year progresses.
Cisco is extending AI into operations. Nearly 4,500 enterprises had signed up for Cisco Cloud Control by the end of the fourth quarter of fiscal 2026, while Cisco IQ had more than 8,600 customers. Management said AI use across customer experience is raising renewal rates. In September 2026, management said services should turn positive in fiscal 2027 and reach mid-single-digit growth by the year-end as hardware-related services attach.
Solid GuidanceFor the first quarter of fiscal 2027, CSCO expects revenues between $18 billion and $18.2 billion. Non-GAAP earnings are projected at $1.32-$1.34 per share, with a non-GAAP gross margin of 65-66% and an operating margin of 35.5-36.5%.
For fiscal 2027, Cisco projects revenues of $72.2-$73.4 billion and non-GAAP earnings of $5.05-$5.11 per share. Hyperscaler AI infrastructure revenues are expected to reach $7.5 billion, up from approximately $4 billion in fiscal 2026.
Image Source: Zacks Investment Research
Impressive Estimate RevisionsFor first-quarter fiscal 2027 (ending July 2027), the Zacks Consensus Estimate currently shows revenues of $18.09 billion, suggesting an improvement of 21.5% year over year and earnings per share of $1.32, indicating an increase of 32% year over year. The Zacks Consensus Estimate for the current year has improved 14.8% in the last 60 days.
For 2027 (ending July 2027), the Zacks Consensus Estimate currently shows revenues of $73.03 billion, suggesting an improvement of 15.3% year over year and earnings per share of $5.11, indicating an increase of 18% year over year. The Zacks Consensus Estimate for the current year has improved 6.9% in the last 60 days.
Image Source: Zacks Investment Research
Strong Price Upside PotentialThe stock price has rallied 49.2% year to date. Despite this, the stock is currently trading at a forward P/E of 22.97X compared with 23.35X of the industry. The short-term average price target of brokerage firms represents an increase of 16.2% from the last closing price of $114.89. The brokerage target price is currently in the range of $100-$165. This indicates a maximum upside of 43.6% and a downside of 13%.
Image Source: Zacks Investment Research
Investment ThesisCisco Systems currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. CSCO offers an opportunity to invest in a company with substantial unrealized potential in the AI revolution. The astonishing growth potential of the global AI-powered data centers and management’s business visibility offer near-term potential.
IBM Stock Gets $240 Price Target as Truist Questions Timing of AI Demand Summary
Truist began covering IBM with a Hold rating and a $240 price target, citing uncertainty over when enterprise AI investment will translate into stronger deman
IBM (IBM) received a Hold rating from Truist Securities on Friday as the firm began covering the technology company with a $240 price target.
The move puts the focus on whether its AI-related offerings can generate customer demand soon enough to offset execution concerns, according to a Friday analyst note.
Analyst Arvind Ramnani sees IBM as having several routes into enterprise AI. Its mainframe systems handle transaction workloads, watsonx Orchestrate coordinates tasks across AI models, and Red Hat software supports applications across private data centers and cloud platforms. IBM also provides consulting to help businesses put AI tools into use.
The central question is when corporate investment in AI infrastructure will begin translating into more demand for IBM. Truist highlighted uncertainty about that timeline alongside the company's second-quarter 2026 results, which missed expectations and preceded a sell-off of more than 20%.
Following the decline, IBM trades at about 17 times forward earnings, a valuation Truist considers reasonable. Still, the Hold recommendation reflects a wait-and-see stance: IBM has businesses positioned around AI, but the timing and scale of commercial returns remain uncertain.
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Akcie Phillips 66 (PSX) za poslední měsíc vzrostly o 8,9 % na nové 52týdenní maximum 282,64 USD; zisk na akcii (EPS) ve výši 9,41 USD překonal konsensus ve výši 7,68 USD.
A strong stock as of late has been Phillips 66 (PSX - Free Report) . Shares have been marching higher, with the stock up 8.9% over the past month. The stock hit a new 52-week high of $282.64 in the previous session. Phillips 66 has gained 118.2% since the start of the year compared to the 37.2% move for the Zacks Oils-Energy sector and the 150.3% return for the Zacks Oil and Gas - Refining and Marketing industry.
What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on August 5, 2026, Phillips 66 reported EPS of $9.41 versus consensus estimate of $7.68.
For the current fiscal year, Phillips 66 is expected to post earnings of $29.01 per share on $157.49 in revenues. This represents a 350.47% change in EPS on a 15.33% change in revenues. For the next fiscal year, the company is expected to earn $29.79 per share on $147.13 in revenues. This represents a year-over-year change of 2.66% and -6.58%, respectively.
Valuation MetricsThough Phillips 66 has recently hit a 52-week high, what is next for Phillips 66? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Phillips 66 has a Value Score of B. The stock's Growth and Momentum Scores are A and B, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 9.7X current fiscal year EPS estimates, which is a premium to the peer industry average of 8.9X. On a trailing cash flow basis, the stock currently trades at 19.1X versus its peer group's average of 12X. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Zacks RankWe also need to look at the Zacks Rank for the stock, as this is even more important than the company's VGM Score. Fortunately, Phillips 66 currently has a Zacks Rank of #1 (Strong Buy) thanks to favorable earnings estimate revisions from covering analysts.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Phillips 66 passes the test. Thus, it seems as though Phillips 66 shares could still be poised for more gains ahead.
How Does PSX Stack Up to the Competition?Shares of PSX have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is PBF Energy Inc. (PBF - Free Report) . PBF has a Zacks Rank of #1 (Strong Buy) and a Value Score of A, a Growth Score of A, and a Momentum Score of A.
Earnings were strong last quarter. PBF Energy Inc. beat our consensus estimate by 53.58%, and for the current fiscal year, PBF is expected to post earnings of $24.69 per share on revenue of $39.14 billion.
Shares of PBF Energy Inc. have gained 15.9% over the past month, and currently trade at a forward P/E of 3.62X and a P/CF of 55.51X.
The Oil and Gas - Refining and Marketing industry is in the top 2% of all the industries we have in our universe, so it looks like there are some nice tailwinds for PSX and PBF, even beyond their own solid fundamental situation.
Oppenheimer just handed Fastly a rare upgrade, arguing the market is sleeping on something sitting directly in front of one of tech's fastest-growing workloads. Whether the trade holds depends on products that launched weeks ago and have yet to earn…
Fastly (NYSE:FSLY) shares gained 15% to $29.04 after Oppenheimer upgraded the edge network operator to Outperform from Neutral. The call highlights how directly Fastly’s traffic-metered business sits in front of fast-growing artificial intelligence (AI) workloads, a link Oppenheimer believes the market hasn’t fully priced.
Meanwhile, Datadog (NASDAQ:DDOG | DDOG Price Prediction) shares are at $284.62, up 4%. Cloudflare (NYSE:NET) stock is at $350.31, up 2%, trailing Fastly despite running the same kind of edge network.
For a sector read, the First Trust Cloud Computing ETF (NASDAQ:SKYY) is up 1.6%, lagging both Cloudflare and Datadog shares. A wider benchmark, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY), is up 0.5%. The cloud sector is being bid as a group, while Fastly stock’s far larger move shows that the upgrade doing much of the work.
Oppenheimer Points to Bigger Deals and AI Agent Traffic Oppenheimer analyst Param Singh coupled the upgrade with a $35 price target on Fastly stock, building the call on industry checks. Those checks point to rising average deal sizes as customers add Fastly’s newer security products, and they also flag early monetization of agentic AI traffic, which raises network volume and demand for its bot management tools.
Singh argued that Fastly stock trades at a steep discount to other infrastructure software vendors and that the gap can narrow as growth comes through. The newest products in Fastly’s security lineup (AI Runtime, AI Firewall and API Enforcement) reached general availability in September. None of the three has contributed significantly to revenue yet, so the cross-sell the upgrade is built on still lies ahead.
Why Fastly Is Moving Harder Than Cloudflare and Datadog Fastly runs a content delivery and edge security network and charges largely on traffic volume, so automated requests from AI agents flow straight into its billing.
Cloudflare, the closest and much larger comparison, runs the same kind of edge network with a broader platform on top. Datadog sells observability software, a weaker link to the same trend. That difference in direct exposure lines up with Fastly’s bigger move.
On the bullish side, a traffic-metered business sits in front of a fast-growing workload, and Singh’s discount argument leaves room for a rerate. Rising security deal sizes would add a second engine, part of the same AI expansion we mapped across power, cooling, and networking suppliers in a free report on seven AI infrastructure names.
The bear case: an upgrade built on industry checks and weeks-old products is still an expectation waiting for proof. Fastly has also long been the smaller competitor in a market Cloudflare has been winning, and a steep discount can persist if growth comes in slower.
What to Watch Next Signs that AI Runtime, AI Firewall and API Enforcement are lifting average deal sizes will be worth watching, along with bot management demand tied to agentic AI traffic, which connects the AI theme most directly to the metered network.
Fastly stock at $29.04 still sits below Param Singh’s $35 target. However, a 15% jump on an upgrade tied to products that launched in September leaves the shares exposed to any sign the cross-sell is arriving slowly. Until the new security tools show up in reported revenue, position sizes should stay measured.
Contact [email protected] for any questions or corrections.
Costco (COST - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this warehouse club operator have returned +5.1% over the past month versus the Zacks S&P 500 composite's +1.3% change. The Zacks Retail - Discount Stores industry, to which Costco belongs, has gained 2.9% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Costco is expected to post earnings of $4.89 per share for the current quarter, representing a year-over-year change of +12.7%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.4%.
The consensus earnings estimate of $22.87 for the current fiscal year indicates a year-over-year change of +11.8%. This estimate has changed +1.6% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $24.94 indicates a change of +9.1% from what Costco is expected to report a year ago. Over the past month, the estimate has changed +1.8%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Costco.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
In the case of Costco, the consensus sales estimate of $73.99 billion for the current quarter points to a year-over-year change of +9.9%. The $328.42 billion and $351.91 billion estimates for the current and next fiscal years indicate changes of +8.3% and +7.2%, respectively.
Last Reported Results and Surprise HistoryCostco reported revenues of $95.72 billion in the last reported quarter, representing a year-over-year change of +11.1%. EPS of $6.6 for the same period compares with $5.87 a year ago.
Compared to the Zacks Consensus Estimate of $94.82 billion, the reported revenues represent a surprise of +0.95%. The EPS surprise was +1.85%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Costco is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Costco. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Realty Income ve druhém čtvrtletí 2026 meziročně zvýšila upravené prostředky z provozní činnosti (AFFO) na akcii o 3,8 % na 1,09 USD; obsazenost portfolia činila 98,8 %.
Key Takeaways Realty Income owns 15,588 properties across 92 industries, with 98.8% occupancy and 8.6-year leases.Triple-net leases and a 102.7% rent recapture rate support predictable cash flows and higher rental income.Investment-grade tenants account for 34.3% of ABR, while the top 20 tenants contribute 34.8%. Realty Income (O - Free Report) continues to demonstrate the resilience of its net-lease portfolio, supported by high occupancy, a diversified tenant base and long-term leases. As of June 30, 2026, the company owned 15,588 properties leased to 1,798 clients across 92 industries. Occupancy stood at a healthy 98.8%, while the weighted-average remaining lease term of 8.6 years provides strong visibility into future rental income.
The company’s tenant diversification helps support portfolio stability. Investment-grade clients accounted for 34.3% of annualized base rent (ABR), while its top 20 tenants contributed 34.8%. Although retail properties represented 78.3% of ABR, Realty Income’s presence across multiple industries helps broaden its revenue base and reduce reliance on any single tenant or sector.
Realty Income’s triple-net lease structure further supports predictable cash flows, as tenants generally cover property taxes, insurance and maintenance expenses. The company also demonstrated effective leasing execution, achieving an overall rent recapture rate of 102.7%. Rent recapture reached 104.6% for existing clients, highlighting its ability to secure higher rents when renewing leases with current tenants.
Growth in rental income remains steady. Same-store rental revenues increased 1.2% year over year in the second quarter of 2026, in line with the company’s full-year growth outlook of 1.1-1.3%. Meanwhile, adjusted funds from operations (AFFO) per share rose 3.8% year over year to $1.09, reflecting continued progress in supporting shareholder returns.
With strong occupancy, long-term leases and solid tenant retention, Realty Income is positioned to sustain dependable rental income and gradual AFFO growth. While new-tenant leasing economics and tenant credit quality warrant monitoring, its diversified portfolio and established leasing platform provide a solid foundation for long-term performance.
How Are Realty Income’s Competitors Managing Tenant Risk?Agree Realty Corporation’s (ADC - Free Report) portfolio occupancy was 99.8%, with 2,825 properties and 65.8% investment-grade tenant exposure in the second quarter of 2026. The company achieved 105% rent recapture, reflecting strong leasing performance.
NNN REIT, Inc. (NNN - Free Report) maintained a diversified portfolio of 3,774 properties, with occupancy of 99.1% and a weighted-average remaining lease term of 10.1 years in the second quarter of 2026. Annualized base rent increased 7.3% to $959.1 million. Its largest tenants included 7-Eleven, Mister Car Wash and Dave & Buster's, contributing 4.2%, 3.7% and 3.5% of annualized base rent, respectively.
Realty Income’s Price Performance, Valuation and EstimatesShares of Realty Income have dipped 14.4% over the past three months, underperforming the broader industry and the S&P 500 Index.
Image Source: Zacks Investment Research
In terms of forward 12-month Price/Earnings (P/E), Realty Income is currently trading at 11.91X, which is at a discount to the industry average of 15.06X.
Image Source: Zacks Investment Research
Realty Income’s estimate revisions reflect a negative trend. The Zacks Consensus Estimate for fiscal 2026 EPS has been revised downward by a cent over the past month. The consensus estimate calls for 3.3% growth year over year.
Image Source: Zacks Investment Research
Currently, Realty Income carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
DaVita ve druhém čtvrtletí překonala očekávání ohledně upraveného provozního zisku v segmentu IKC o 40 milionů USD, a to díky růstu objemu léčby a investicím do technologií.
Key Takeaways DaVita is benefiting from IKC growth, improving treatment volumes and technology investments.IKC beat expectations by $40 million in adjusted operating income in the second quarter.DaVita faces commercial-mix pressure, elevated G&A costs and limited acquisition opportunities. DaVita Inc. (DVA - Free Report) has been gaining from strong execution across its Integrated Kidney Care (“IKC”) platform, improving treatment volumes and investments in technology and clinical innovation. The optimism is driven by solid first-quarter 2026 results and higher full-year guidance. However, intense competition, commercial payer-mix pressures and regulatory and macroeconomic uncertainty remain key concerns.
Year to date, this Zacks Rank #3 (Hold) stock has rallied 55.8%, outperforming the industry’s 19.8% growth and the S&P 500’s 14.5% gain.
The renowned global comprehensive kidney care provider has a market capitalization of $11.28 billion. The company projects 26.5% growth over the next five years and expects to maintain its strong performance going forward. DaVita’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and missed once, the average surprise being 0.14%.
Image Source: Zacks Investment Research
DVA’s Prospect DriversIKC Offers a Scalable Earnings Growth Opportunity: IKC is emerging as a meaningful avenue for DaVita to diversify growth beyond traditional dialysis operations. Management said IKC generated $40 million of adjusted operating income above expectations in the second quarter, although timing of revenue recognition was a major factor.
The company sees significant growth opportunities through improved economics and an expansion in the number of people and dollars under management. Management also expects to add more contracts with Medicare Advantage plans. As the model matures, closer coordination among nephrologists, clinics and DaVita could enhance care management and drive a growing contribution to operating earnings.
Improving Treatment Economics Could Support Margin Expansion: DaVita is seeing signs of moderating per-treatment cost pressures as treatment volumes improve.Patient care cost per treatment declined approximately $3 sequentially in the second quarter, primarily because higher treatment volumes created operating leverage on labor and other fixed costs, while lower phosphate-binder expenses provided an additional benefit.
Although year-to-date patient care costs remained above the company’s full-year target, management expects year-over-year cost growth to decelerate in the second half as phosphate-binder expenses decline and facility-maintenance growth moderates. If treatment volumes continue improving, greater absorption of fixed operating expenses could provide incremental earnings leverage even without significant increases in revenue per treatment.
Stronger Formulary Adoption Can Improve Treatment Quality and Utilization: DaVita’s broad phosphate-binder formulary is generating an important clinical and operational benefit following the transition of these medications into the Medicare dialysis bundle. Management said the number of patients relying on less-effective over-the-counter alternatives such as TUMS has fallen by more than 50%, allowing more patients to receive clinically preferred therapies.
Better phosphate management can reduce risks associated with cardiovascular complications and bone fractures, supporting improved patient outcomes over time. The development also demonstrates DaVita’s ability to implement major treatment-policy changes across its network. As the company continues optimizing bundled-care protocols, stronger treatment adherence and clinical consistency could support its broader quality-of-care strategy.
Key RisksRevenue per Treatment Faces Persistent Commercial-Mix Pressure: DaVita’s biggest near-term earnings constraint may come from declining revenue per treatment rather than treatment volumes. Revenue per treatment (RPT) declined approximately $2 sequentially during the second quarter, primarily because of lower commercial mix following the expiration of ACA subsidies and reduced phosphate-binder revenues.
Management expects full-year RPT growth of only 1-2%, implying slightly negative year-over-year RPT growth in the second half. The company estimates that the commercial-mix shift could represent a roughly $70 million impact in 2027, as new patient admissions increasingly arrive with lower commercial coverage. This creates a structural offset to volume growth and limits the earnings benefit from improving treatment volumes.
Elevated Corporate and Operating Expenses Could Limit Volume Leverage: Despite treatment growth, DaVita has not yet translated the improvement fully into U.S. dialysis operating-income growth. Management noted that U.S. dialysis operating income was relatively flat year over year in the second quarter, with G&A growth of roughly 10% acting as one of the principal offsets. This is particularly important as treatment volumes increase while the company faces higher administrative expenses.
If G&A remains elevated, incremental treatment volumes may generate less operating leverage than investors expect. Management needs continued discipline around corporate costs to ensure that improving clinical outcomes and treatment volumes translate into stronger segment profitability rather than being absorbed by higher overhead.
Limited Acquisition Opportunities Could Constrain External Growth: DaVita’s ability to accelerate growth through acquisitions appears increasingly limited because the U.S. dialysis market has become highly consolidated.
Management said there are still smaller clinic opportunities available, but characterized the market as having relatively few acquisition targets. Consequently, future domestic expansion is expected to rely more heavily on de novo clinics as industry treatment volumes improve. This shifts the growth profile toward internally developed capacity, which generally requires more time to build patient density and establish operating maturity.
While the strategy can support long-term expansion, the scarcity of attractive acquisition opportunities reduces DaVita’s ability to rapidly increase market share through inorganic growth and places greater importance on execution of its organic expansion pipeline.
Estimate TrendDaVita is witnessing a stable estimate revision trend for 2026. Over the past 30 days, the Zacks Consensus Estimate for earnings per share has remained unchanged at $14.57.
The Zacks Consensus Estimate for the company’s third-quarter 2026 revenues is pegged at $3.53 billion, indicating a 3.2% uptick from the year-ago quarter’s reported number. The consensus mark for earnings is pegged at $3.78 per share, implying 50.6% year-over-year growth.
Stocks to ConsiderSome better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , Outset Medical (OM - Free Report) and Merit Medical Systems (MMSI - Free Report) .
Globus Medical, currently carrying a Zacks Rank #2 (Buy), reported a second-quarter 2026 adjusted EPS of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in each of the trailing four quarters, with the average surprise being 27.9%.
Outset Medical, carrying a Zacks Rank #2 at present, reported second-quarter 2026 loss per share of 80 cents, which missed the Zacks Consensus Estimate by 26.9%. Revenues of $32 million surpassed the Zacks Consensus Estimate by 9.8%.
OM has an estimated earnings growth rate of 28.4% for 2027. OM’s earnings missed estimates in each of the trailing four quarters, with the average negative surprise being 31.63%.
Merit Medical Systems, currently carrying a Zacks Rank of 2, reported a second-quarter 2026 adjusted EPS of $1.19, which surpassed the Zacks Consensus Estimate by 24%. Revenues of $419 million beat the Zacks Consensus Estimate by 3.5%.
MMSI has an estimated long-term earnings growth rate of 10.4%. The company’s earnings beat estimates in each of the trailing four quarters, with the average surprise being 14.10%.
YHB Investment Advisors Inc. lowered its position in Micron Technology, Inc. (NASDAQ:MU – Free Report) by 48.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 859 shares of the semiconductor manufacturer’s stock after selling 811 shares during the period. YHB Investment Advisors Inc.’s holdings in Micron Technology were worth $915,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Denali Advisors LLC purchased a new position in Micron Technology during the 2nd quarter valued at about $7,364,000. Castleark Management LLC bought a new stake in Micron Technology during the first quarter worth about $3,709,000. Legacy Wealth Management LLC MS grew its holdings in Micron Technology by 73.3% in the second quarter. Legacy Wealth Management LLC MS now owns 3,544 shares of the semiconductor manufacturer’s stock worth $4,091,000 after purchasing an additional 1,499 shares during the period. Oppenheimer & Co. Inc. grew its holdings in Micron Technology by 16.0% in the second quarter. Oppenheimer & Co. Inc. now owns 48,520 shares of the semiconductor manufacturer’s stock worth $56,006,000 after purchasing an additional 6,702 shares during the period. Finally, Franklin Street Advisors Inc. NC increased its stake in shares of Micron Technology by 2,461.4% during the second quarter. Franklin Street Advisors Inc. NC now owns 37,141 shares of the semiconductor manufacturer’s stock valued at $42,871,000 after purchasing an additional 35,691 shares in the last quarter. Hedge funds and other institutional investors own 80.84% of the company’s stock.
Insider Buying and Selling at Micron Technology In other Micron Technology news, CEO Sanjay Mehrotra sold 40,000 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $968.90, for a total value of $38,756,000.00. Following the transaction, the chief executive officer directly owned 264,503 shares of the company’s stock, valued at approximately $256,276,956.70. This trade represents a 13.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Scott Allen sold 879 shares of the business’s stock in a transaction dated Thursday, July 23rd. The shares were sold at an average price of $1,000.00, for a total value of $879,000.00. Following the sale, the chief accounting officer owned 34,958 shares of the company’s stock, valued at approximately $34,958,000. This represents a 2.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 95,879 shares of company stock valued at $90,939,466. 0.24% of the stock is owned by company insiders.
Wall Street Analyst Weigh In Several research firms have recently issued reports on MU. Itau BBA Securities lifted their target price on shares of Micron Technology from $1,243.78 to $1,697.09 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Seaport Research Partners restated a “buy” rating on shares of Micron Technology in a research note on Friday, August 14th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $2,000.00 price objective on shares of Micron Technology in a research report on Thursday, October 1st. Robert W. Baird lifted their price objective on Micron Technology from $1,280.00 to $1,520.00 and gave the company an “outperform” rating in a research note on Monday, September 28th. Finally, Argus dropped their target price on Micron Technology from $1,500.00 to $540.00 and set a “buy” rating on the stock in a report on Thursday, June 25th. One equities research analyst has rated the stock with a Strong Buy rating, forty-one have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $1,407.88. View Our Latest Analysis on Micron Technology
Micron Technology Trading Down 4.8% NASDAQ:MU opened at $1,035.84 on Friday. The company has a market cap of $1.17 trillion, a PE ratio of 13.96, a price-to-earnings-growth ratio of 0.19 and a beta of 2.22. The company has a current ratio of 3.31, a quick ratio of 2.94 and a debt-to-equity ratio of 0.03. The company has a 50 day simple moving average of $975.93 and a two-hundred day simple moving average of $840.54. Micron Technology, Inc. has a 12 month low of $179.61 and a 12 month high of $1,255.00.
Micron Technology (NASDAQ:MU – Get Free Report) last released its quarterly earnings results on Wednesday, September 30th. The semiconductor manufacturer reported $33.42 earnings per share for the quarter, beating the consensus estimate of $31.77 by $1.65. The firm had revenue of $54.23 billion for the quarter, compared to analysts’ expectations of $51.33 billion. Micron Technology had a return on equity of 92.62% and a net margin of 63.80%.The company’s revenue was up 379.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.03 EPS. Micron Technology has set its Q1 2027 guidance at 37.150-39.150 EPS. Research analysts forecast that Micron Technology, Inc. will post 175.82 earnings per share for the current year.
Micron Technology Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Thursday, October 29th. Shareholders of record on Wednesday, October 14th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Wednesday, October 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.1%. Micron Technology’s dividend payout ratio is currently 0.81%.
Micron Technology News Roundup Here are the key news stories impacting Micron Technology this week:
Positive Sentiment: Strong earnings and forward guidance support the growth outlook. Micron reported fiscal fourth-quarter revenue of $54.23 billion and adjusted earnings of $33.42 per share, both ahead of expectations. Management also projected fiscal first-quarter 2027 adjusted EPS of $37.15-$39.15, implying another sequential increase. Micron’s Latest Earnings Reveal Why the AI Memory Supercycle Could Run for Years Positive Sentiment: AI-related demand remains a major catalyst. More than 75% of Micron’s fiscal 2027 output is reportedly committed, while customers are already discussing 2028 allocations. Record DRAM revenue and surging enterprise SSD demand suggest data-center customers are securing memory supply well in advance. Micron: This Memory Cycle Could End Differently Positive Sentiment: Analyst support remains strong. Zacks upgraded Micron to “Strong Buy,” while D.A. Davidson raised its price target to $3,000 and maintained a Buy rating, citing a potential multiyear shortage driven by AI infrastructure spending. Micron & 2 Profitable Stocks to Buy in October for Big Upside Neutral Sentiment: Valuation and cyclicality remain debated. Bullish analysts view Micron’s roughly six-to-seven-times forward earnings valuation as inexpensive, but skeptics warn that margins may be near a peak and that memory prices could eventually normalize. A $600 million settlement with Netlist also removes a legal overhang but adds a material cost. Micron Technology, Netlist Settle Patent Dispute for $600 Million Negative Sentiment: Investors reacted negatively to weaker-than-expected AI revenue concerns. A report that OpenAI’s annualized revenue was below expectations triggered a broader selloff in AI and semiconductor stocks. Analysts said the figure may reflect reporting differences rather than a deterioration in AI demand, but the news heightened concern about crowded AI valuations. Micron, Nvidia and AI chip stocks fall as report on OpenAI’s revenue causes undue concern Negative Sentiment: A Taiwan labor dispute adds operational risk. Workers at Micron’s major Taiwan manufacturing sites authorized a strike over bonus changes. No walkout has been announced, but a disruption could threaten production and increase costs. Micron’s Taoyuan union in Taiwan secures authorisation to strike Negative Sentiment: Samsung’s record profit did not reassure memory investors. Although Samsung reported sharply higher operating profit, the slower pace of growth and concerns that the memory cycle is nearing a peak reinforced fears that Micron’s exceptional earnings growth may decelerate. The Memory Trade Cools After Samsung’s Preliminary Results Disappoint (Free Report)
Micron Technology, Inc is a semiconductor company that develops and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, three-dimensional XPoint-related technologies, solid-state drives, and high-bandwidth memory products designed for demanding computing applications.
The company serves customers across the data center, artificial intelligence, networking, automotive, industrial, mobile, consumer electronics, and embedded markets.
See Also Five stocks we like better than Micron Technology Want Private-Market Access to Kalshi and Polymarket? Try This ETF Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.
Podle autora má Micron k dispozici 32 miliard USD v bezúročných zálohách od zákazníků a dlouhodobé smlouvy, které snižují riziko spojené s kapitálovými výdaji.
SummaryMicron is positioned as an AI infrastructure toll-collector, benefiting from surging agentic AI memory demand and strategic customer agreements (SCAs).MU’s $32 billion in zero-interest client deposits and long-term SCAs de-risk capital spending, supporting robust margins even in downturns.Rising HBM complexity and wafer trade ratios constrain physical memory supply, countering oversupply fears despite $50B+ annual CapEx.I rate MU a strong buy, citing a 5.88x forward P/E as a valuation anomaly amid multi-year supply deficits and imminent buybacks. knowlesgallery/iStock Editorial via Getty Images
In my last article, Micron Technology, Inc. (MU) stock was marked as a buy. Because over the long term, in my opinion, Micron is moving towards being a (kind-of) SaaS AI infrastructure toll-collector. Under the excessive and continued
2.19K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Micron ve fiskálním roce 2026 zvýšil tržby o 256,3 % na 133,19 miliardy USD. V 1. čtvrtletí fiskálního roku 2027 očekává tržby ve výši 61,5 miliardy USD.
Every time Micron dips, one investor keeps buying more shares, and the reasoning has nothing to do with short-term momentum. The structural case building behind this memory giant may be one of the quieter conviction plays unfolding in AI right…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
My position in Micron Technology (NASDAQ:MU | MU Price Prediction) grew again this week, and I already know I’ll repeat the move. Shares fell 4.79% on Thursday to $1,035.84 after a report on OpenAI’s revenue rattled AI chip stocks. I treated that dip the way I treat every dip in this name: as another entry point.
Here is what keeps pulling me back. Memory used to be a commodity that boomed and busted. AI changed that math. Every model with longer context and more users needs more memory, and Micron makes the HBM, DRAM, and data center SSDs those systems run on. Management says it has “no line of sight to when supply and demand will return to balance.” I want to own the bottleneck.
Three Receipts Behind Every Purchase First, the earnings engine. Fiscal 2026 revenue reached $133.19 billion, up 256.3%, with non-GAAP EPS of $75.52. Fourth-quarter gross margin hit 87.0% versus 45.7% a year earlier, marking the 8th consecutive EPS beat. Guidance for fiscal Q1 2027 calls for $61.5 billion in revenue and EPS of $38.15.
Second, visibility. Micron has signed 26 strategic customer agreements, all with take-or-pay volumes. Remaining performance obligations sit near $150 billion, customer commitments total $32 billion, and more than 75% of 2027 output is already committed. Management expects margins even at floor prices to sit significantly above any prior cycle peak.
The balance sheet stands out too. Micron ended the quarter with $68.3 billion in net cash, earned BBB+ ratings from all three agencies, and produced $33.20 billion in quarterly free cash flow. Starting December 9, 2026, management plans to step up capital returns, aiming over time to return 100% of excess cash, mostly through buybacks. The $0.15 quarterly dividend followed a 30% raise. I own this for compounding and share count reduction, with income as a bonus.
Why My Money Goes Here Instead of NVIDIA The AI name everyone reaches for first is NVIDIA (NASDAQ:NVDA). I pass on it for valuation. NVIDIA trades at 30 times trailing earnings and 25 times forward earnings, with a price-to-sales ratio of 18.93. Micron trades at 14 times trailing, 7 times forward, and 9.23 times sales. I still get NVIDIA’s roadmap through Micron, which is building “the industry’s first custom HBM4E implementation, NVHBM” with it.
Risks That Keep Me Disciplined Memory remains cyclical. Capex ran $30.71 billion in fiscal 2026, and first-half fiscal 2027 spending should reach about $25 billion. HBM4 volume leans on a lead customer, a Taiwan union won approval to strike, and a beta of 2.226 guarantees violent swings. If AI spending slows or rivals add capacity faster than expected, pricing breaks.
I accept that. Floor-priced, take-or-pay contracts and a large cash pile give Micron room to weather a downturn that would have crushed the old Micron.
What Keeps My Buy Button Active Idaho’s ID1 fab should begin wafer output in mid-calendar 2027, HBM4E volume production arrives in calendar 2027, and Level 4 autonomous vehicles need more than 200 gigabytes of memory each. CEO Sanjay Mehrotra put it simply: “As strong as fiscal 2026 was, we expect fiscal 2027 to be even better.” (The signs that show up years before a monster tech run are the ones we cataloged in a free playbook here: The Next Nvidia Playbook.)
While the world keeps running short of memory, I will keep buying the company that makes it.
Contact [email protected] for any questions or corrections.
BlackBerry získala od společnosti Coretura první kontrakt pro Alloy Kore, který představuje největší zakázku pro QNX v její historii a přinese více než 100 milionů USD v budoucích licenčních výnosech.
Key Takeaways BB secured its first Alloy Kore design win with Coretura, its largest QNX award to date.The Coretura deal adds over $100 million in future royalties to QNX's $950M backlog.Alloy Kore's price is roughly 3x current QNX deployments, but its FY2027 revenue impact will be limited. BlackBerry Limited (BB - Free Report) has secured its first Alloy Kore design win, giving investors a clearer view of how the platform could expand QNX’s role in software-defined vehicles. The Coretura award is the largest design win in QNX history.
The agreement adds more than $100 million in expected future royalties. That creates a meaningful long-term opportunity, although the timing of production will determine when those royalties become revenues.
BlackBerry Lands a Landmark Alloy Kore WinCoretura, the commercial-vehicle software joint venture between Volvo Group and Daimler Truck, selected Alloy Kore as the foundational software platform for its next-generation high-performance compute architecture. The planned deployment spans multiple software domains.
The win moves Alloy Kore from a strategic initiative to commercial validation. BlackBerry designed the platform with Vector middleware, common automotive services and QNX foundational software to reduce integration complexity for automakers.
BB Adds More Than $100 Million to QNX BacklogThe Coretura award is expected to contribute more than $100 million of future royalties. QNX’s royalty backlog stood at approximately $950 million at the end of fiscal 2026, giving the new contract notable scale relative to the existing base.
Backlog does not equal immediate revenue. Royalties generally depend on awarded vehicle programs reaching production, so the added value improves BlackBerry’s long-term visibility rather than providing an instant lift to reported results.
BlackBerry Can Capture More Software Value per VehicleManagement said the Alloy Kore average selling price per instance in the Coretura win is approximately three times the customer’s current QNX operating-system deployment. That supports BlackBerry’s strategy of moving higher in the automotive software stack.
The broader industry is also investing in centralized vehicle computing. NVIDIA Corporation (NVDA - Free Report) positions its Hyperion platform as a production-ready architecture for autonomous vehicles, while Qualcomm Incorporated (QCOM - Free Report) offers the Snapdragon Digital Chassis as an integrated platform for software-defined vehicles. Those efforts underscore the shift toward software-heavy vehicle architectures.
BB’s Near-Term Revenue Benefit Will Be LimitedThe size of the award should not be confused with near-term revenue. Management does not expect the Coretura design win to materially change BlackBerry’s fiscal 2027 revenue profile because most royalties will be realized after vehicles enter production.
That timing makes execution important. Production schedules, program launches and customer volumes will determine the pace at which the contracted opportunity converts into QNX revenue and cash flow.
BlackBerry’s Win Broadens Its Automotive OpportunityCoretura gives BlackBerry a reference customer for Alloy Kore and supports its push to increase software content per vehicle. QNX is also benefiting from growing adoption of higher-performance centralized computing architectures and multiple QNX instances in a single vehicle.
BlackBerry said it is pursuing additional Alloy Kore opportunities with global automakers and major Tier 1 suppliers, particularly in Europe and Asia. Further wins could expand QNX’s royalty runway, but each program will still carry a lead time before production revenue becomes material.
BB’s Growth Profile Gets Support From QNXThe Alloy Kore win strengthens the long-term QNX opportunity, but it does not remove the timing risk between design wins and royalty recognition. Investors therefore have a larger contracted opportunity to monitor, not an immediate earnings contribution of the same size.
BlackBerry currently carries a Zacks Rank #3 (Hold). Its Growth Score of A and Momentum Score of A are favorable, while the Value Score of F points to weaker value characteristics. The VGM Score of B is constructive, but the Zacks Rank suggests a measured stance while investors track execution and backlog conversion. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
BlackBerry ve druhém čtvrtletí fiskálního roku 2027 vytvořila volný peněžní tok ve výši 28 mil. USD a zvýšila výhled provozního peněžního toku na přibližně 115 mil. USD.
Key Takeaways BB ended fiscal Q2 with $447 million in cash and investments, including nearly $247 million in net cash.BB generated $28 million in quarterly free cash flow and raised its fiscal 2027 operating cash flow outlook.BlackBerry is prioritizing QNX investments, disciplined share buybacks and selective M&A to support growth. BlackBerry Limited’s (BB - Free Report) improving profitability and cash generation have strengthened its balance sheet. The company ended the second quarter of fiscal 2027 with approximately $447 million in cash and investments, representing net cash of nearly $247 million.
A stronger balance sheet reduces financial pressure while giving BlackBerry options to support its growth initiatives.
Strong Cash Generation Bolsters Financial FlexibilityBlackBerry generated $29.3 million in operating cash flow in the fiscal second quarter, above management's guidance. For the first half of fiscal 2027, operating cash flow totaled $34 million, while cash usage was $14 million in the year-ago period. Free cash flow reached $28 million in the quarter and $30 million in the first half, supported by the company's capex-light operating model.
This improvement reflects stronger operating leverage and revenue growth. Fiscal second-quarter revenues of $163.3 million rose 26% and came in 14.2% above the Zacks Consensus Estimate. Adjusted gross margin improved to 78.2% from 75% a year earlier. Adjusted EBITDA increased 81% to $47 million and represented 29% of revenues.
Management also raised its fiscal 2027 operating cash flow outlook by $15 million to approximately $115 million, signaling confidence in sustained cash generation.
QNX, Buybacks and M&A in FocusBlackBerry has identified three capital allocation priorities: investing in QNX growth, disciplined share repurchases and selective M&A.
The company is prioritizing organic investments focused on QNX's core automotive business, the Alloy Kore platform and General Embedded Markets (“GEM”).
BlackBerry also retains significant capacity under its existing normal course issuer bid share repurchase program. However, management intends to evaluate buybacks against alternative investment opportunities and repurchase shares when attractive relative to other opportunities.
Meanwhile, BlackBerry is assessing potential acquisitions that could accelerate expansion into the GEM space.
Though improving cash position provides room to pursue multiple growth initiatives, the pace of acquisitions and repurchases will depend on available opportunities and management's disciplined capital allocation approach.
Cash Profile for PeersAptiv PLC (APTV - Free Report) is an automotive technology peer for BlackBerry's QNX business. At the end of the second quarter of 2026, Aptiv had $761 million in cash and cash equivalents. It generated $12 million in free cash flow during the quarter and expects full-year 2026 free cash flow of $625 million to $725 million.
Aptiv repurchased $250 million worth of shares in the quarter, bringing first-half buybacks to $325 million. On the last earnings call, management said that it intends to return approximately half of its free cash flow to shareholders through repurchases over the next few years. Meanwhile, smaller bolt-on acquisitions remain a priority to diversify operations.
Cybersecurity peer CrowdStrike Holdings (CRWD - Free Report) is also leveraging its financial strength to pursue strategic growth opportunities.
The company ended second-quarter fiscal 2027 with $5.01 billion in cash and cash equivalents. It generated operating cash flow of $530 million and free cash flow of $377 million in the quarter. CrowdStrike expects a free cash flow margin of at least 30% for fiscal 2027. Long-term debt was about $746.2 million as of July 31, 2026, leaving the company with ample financial flexibility. CrowdStrike’s capital deployment strategy includes acquiring XM Cyber's technology assets to strengthen exposure management capabilities. The transaction is expected to close in the second half of fiscal 2027.
BB Price Performance, Valuation & EstimatesBlackBerry’s shares have gained 14.5% in the past month compared with the Internet-Software industry’s 8.3% growth.
Image Source: Zacks Investment Research
The stock is trading at a forward 12-month price-to-earnings multiple of 38.84X, higher than the industry’s multiple of 30.61X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BB earnings for fiscal 2027 has been revised upward over the past 60 days.
Image Source: Zacks Investment Research
BlackBerry currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Eli Lilly (LLY - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Over the past month, shares of this drugmaker have returned +4.2%, compared to the Zacks S&P 500 composite's +1.3% change. During this period, the Zacks Large Cap Pharmaceuticals industry, which Lilly falls in, has gained 0.3%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Lilly is expected to post earnings of $9.83 per share for the current quarter, representing a year-over-year change of +40%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.1%.
For the current fiscal year, the consensus earnings estimate of $36.64 points to a change of +51.3% from the prior year. Over the last 30 days, this estimate has changed +0.3%.
For the next fiscal year, the consensus earnings estimate of $46.8 indicates a change of +27.7% from what Lilly is expected to report a year ago. Over the past month, the estimate has changed +1.4%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Lilly.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
In the case of Lilly, the consensus sales estimate of $22.14 billion for the current quarter points to a year-over-year change of +25.8%. The $88.88 billion and $102.02 billion estimates for the current and next fiscal years indicate changes of +36.4% and +14.8%, respectively.
Last Reported Results and Surprise HistoryLilly reported revenues of $22.97 billion in the last reported quarter, representing a year-over-year change of +47.7%. EPS of $8.38 for the same period compares with $6.31 a year ago.
Compared to the Zacks Consensus Estimate of $20.26 billion, the reported revenues represent a surprise of +13.38%. The EPS surprise was +39.43%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Lilly is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Lilly. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Union Pacific plánuje akvizici společnosti Norfolk Southern za 85 mld. USD, která by vytvořila první transkontinentální železnici v USA s více než 52 000 mílemi tratí.
Union Pacific (UNP -0.23%) is on the precipice of a game-changing $85 billion merger with Norfolk Southern (NSC -0.04%). The deal would make Union Pacific the first transcontinental railroad in the U.S., with more than 52,000 miles of track.
The merger is not a slam dunk. It has to pass muster with the Surface Transportation Board, with a decision expected sometime next year. A coalition of labor, competitors, and farm groups opposes the merger. The concern is that the merger would create a de facto monopoly and eliminate competition. On the positive side, it could also lead to lower freight costs for shippers and reduced pollution by reducing the need for interstate trucking with single-line coast-to-coast rail service.
The stock is up more than 19% so far this year, and billionaires Chris Hohn, Ken Griffin, and Bill Gates are all among the major owners of Union Pacific through the investment firms they control. Griffin, who owns Citadel, is Union Pacific's leading shareholder, with 2,675,693 shares. Hohn, who owns TCI Fund Management, owns 4,032 shares of the railroad, and Gates, through Cascades, owns 3,435 shares of Union Pacific.
Like most railroads, Union Pacific isn't a high-profile growth stock, but it has a huge economic moat, and the merger would supercharge its potential while trimming transit times by 24 to 48 hours for more than 1 million intermodal loads annually and eliminating roughly 2.1 million truck trips per year, the company said.
Here are three reasons why the stock may make sense for retail investors, not just billionaires.
Image source: Getty Images.
1. Steady growth, solid balance sheet In the second quarter, Union Pacific reported record numbers, including operating revenue of $6.86 billion, up 12% over the same period a year ago; net income of $2 billion, up 6% year over year; and adjusted earnings per share (EPS) of $3.41, up 13% over the same period last year.
Premium Feature
Moneyball Superscore
79/100
Today's Change
(
-0.23
%) $
-0.65
Current Price
$
277.56
The company raised guidance for reported EPS growth to the high single digits this year, consistent with its goals of single- to low-double-digit compound annual growth through 2027.
Because rail remains the most cost-effective way to move bulk commodities, grain, and industrial products over long distances, Union Pacific retains strong pricing power that consistently outpaces inflation.
2. An above-average dividend that is safe The industrial company raised its quarterly dividend by 2.8% this year, the 20th consecutive year it has increased it. The yield on that dividend is 2.01%, and the payout ratio is a safe 50.1%.
The dividend is well protected. Union Pacific reported six-month cash from operations of $5.5 billion, up 21%, year over year. The company has made its dividend even safer by trimming its debt-to-earnings before interest, taxes, depreciation, and amortization (EBITDA) ratio over the past three years.
3. The company already has a huge moat Its merger with Norfolk Southern would mean Union Pacific would operate in 43 states, across more than 52,000 miles of track and serving more than 100 ports. Despite the pushback against the deal, it is likely to be approved because of its benefits to U.S. supply lines, a weakness that emerged during the COVID-19 pandemic. It could also cut costs and improve delivery speeds for essential items, including food.
Even if the deal doesn't go through, Union Pacific is the nation's largest freight railroad, and there's no Class I competitor in sight because of the expense and complications involved in matching its 32,000 miles of track.
The company's network connects Gulf Coast ports to the West Coast and to six leading Mexican routes. That makes it a prime beneficiary of long-term nearshoring trends and North American freight traffic. The company's strong cash flow from operations gives it ample leverage to grow, including pursuing a multibillion-dollar merger.
In its upcoming report, Morgan Stanley (MS - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $2.83 per share, reflecting an increase of 1.1% compared to the same period last year. Revenues are forecasted to be $19.63 billion, representing a year-over-year increase of 7.7%.
The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Morgan Stanley metrics that are commonly tracked and forecasted by Wall Street analysts.
Based on the collective assessment of analysts, 'Net revenues- Institutional Securities' should arrive at $9.21 billion. The estimate suggests a change of +8.1% year over year.
Analysts expect 'Revenues- Wealth Management- Net interest income' to come in at $2.30 billion. The estimate suggests a change of +15.4% year over year.
Analysts forecast 'Revenues- Institutional securities- Investment banking' to reach $2.16 billion. The estimate points to a change of +2.6% from the year-ago quarter.
Analysts' assessment points toward 'Net revenues- Investment Management' reaching $1.47 billion. The estimate points to a change of -11.1% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net revenues- Wealth Management' of $9.01 billion. The estimate indicates a change of +9.4% from the prior-year quarter.
The consensus among analysts is that 'Revenues- Wealth Management- Asset management' will reach $5.40 billion. The estimate indicates a year-over-year change of +12.7%.
According to the collective judgment of analysts, 'Net interest Revenue' should come in at $2.63 billion. The estimate points to a change of +5.4% from the year-ago quarter.
The combined assessment of analysts suggests that 'Revenues- Institutional securities- Other' will likely reach $82.50 million. The estimate indicates a change of -36.5% from the prior-year quarter.
Analysts predict that the 'Revenues- Institutional securities- Sales and trading- Equity' will reach $4.51 billion. The estimate suggests a change of +9.6% year over year.
The consensus estimate for 'Revenues- Investment Management- Performance-based income and other' stands at $62.50 million. The estimate indicates a year-over-year change of -46.6%.
The average prediction of analysts places 'Book value per common share' at $68.61 . Compared to the present estimate, the company reported $62.98 in the same quarter last year.
It is projected by analysts that the 'Return on average common equity' will reach 16.8%. The estimate is in contrast to the year-ago figure of 18.0%.
View all Key Company Metrics for Morgan Stanley here>>>
Shares of Morgan Stanley have demonstrated returns of -11.9% over the past month compared to the Zacks S&P 500 composite's +1.3% change. With a Zacks Rank #3 (Hold), MS is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Lockheed Martin dodá filipínskému letectvu simulátor vrtulníku S-70i Black Hawk, virtuální trenažér údržby a podporu až do roku 2032; jde o první objednávku těchto výcvikových zařízení.
Key Takeaways Lockheed Martin will provide Black Hawk simulators, maintenance training and support through 2032.The deal marks the first order for LMT's S-70i Black Hawk training devices.LMT's 2026 and 2027 EPS estimates show growth of 31.7% and 8.44%, respectively. Lockheed Martin (LMT - Free Report) continues to expand its defense business beyond aircraft manufacturing, with a new contract highlighting the growing role of training and simulation solutions in military modernization.
On Oct. 8, 2026, Lockheed Martin announced that it had signed a Direct Commercial Sale contract with the Philippine Department of National Defense to provide advanced training equipment and services for the Philippine Air Force. The agreement includes an S-70i Black Hawk Full Flight Simulator, a Virtual Maintenance Trainer and associated courseware. The contract also covers sustainment and spare-parts support through 2032.
The Philippines operates Black Hawk helicopters for various missions, including search and rescue, humanitarian assistance, firefighting and troop transport. The full-flight simulator replicates the sights and sensations of flying a Black Hawk, allowing pilots to practice procedures and mission scenarios in a simulated environment. Meanwhile, the Virtual Maintenance Trainer uses detailed, physics-based models of aircraft systems, including hydraulics and avionics, to help maintenance personnel develop technical skills in a risk-free setting.
The contract is also strategically significant because it represents the first order for Lockheed Martin’s S-70i Black Hawk training devices. LMT uses digital-twin technology to replicate aircraft systems and configurations, helping maintain realistic training environments as aircraft capabilities evolve. The agreement could strengthen LMT’s position in the military training market by extending its relationship with customers beyond aircraft procurement into training, maintenance and sustainment.
LMT will continue to train Philippine Air Force Black Hawk pilots at its U.S.-based Sikorsky Training Academy while the country establishes its domestic training capability. This approach supports the transition toward localized training and maintenance operations.
Defense Companies Benefit From Military ModernizationIncreasing defense modernization requirements are creating opportunities for aerospace and defense companies across aircraft manufacturing, mission systems and training technologies. Some industry participants operating in these markets are discussed below:
RTX Corporation (RTX - Free Report) provides advanced defense systems, including missile systems, sensors and other technologies used in military operations. Its broad defense portfolio positions it to participate in modernization programs focused on improving military capabilities.
Northrop Grumman (NOC - Free Report) develops advanced defense technologies spanning aerospace systems, mission solutions and strategic deterrence. Its exposure to complex defense programs provides another example of how military modernization supports demand across the defense industry.
LMT Stock’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 earnings per share indicates a year-over-year improvement of 31.7% and 8.44%, respectively.
Image Source: Zacks Investment Research
LMT Stock Trades at a DiscountIn terms of valuation, LMT’s forward 12-month price-to-sales (P/S) is 1.40X, a discount to the industry’s average of 2.07X.
Image Source: Zacks Investment Research
LMT Stock’s Price PerformanceIn the past three months, the company’s shares have lost 2% compared with the industry’s 14.8% decline.
Image Source: Zacks Investment Research
LMT’s Zacks RankThe company currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Inovace tvořily 23 % tržeb Estée Lauder ve fiskálním roce 2026; ve fiskálním roce 2027 má jejich podíl vzrůst o 200–250 bazických bodů, hlavně díky péči o pleť.
Key Takeaways Innovation accounted for 23% of EL's fiscal 2026 sales, supporting growth across beauty categories.EL expects innovation's sales contribution to rise 200-250 basis points in fiscal 2027, led by skin care.EL's new launches across key beauty categories aim to attract consumers and strengthen brand demand. The Estee Lauder Companies Inc. (EL - Free Report) is sharpening its focus on product innovation to strengthen consumer engagement and drive growth across prestige beauty categories. Under its Beauty Reimagined strategy, the company is launching new products faster, focusing on changing beauty trends and improving popular products to meet consumer needs. Innovation accounted for 23% of fiscal 2026 sales, highlighting its growing role in the company's efforts to attract consumers, strengthen brand appeal and support sales growth.
Innovation supported growth across key categories in fiscal 2026. In skin care, La Mer benefited from offerings such as The NEW Rejuvenating Eye Cream, alongside established franchises, while Estee Lauder gained from innovations and existing products across Advanced Night Repair and Revitalizing Supreme+. Makeup innovation included M·A·C's Skinfinish Colourstruck Blush and TOM FORD's Architecture Radiance Hydrating Foundation. Fragrance also benefited from new offerings across Le Labo, TOM FORD and KILIAN PARIS, reinforcing the role of product development in supporting brand momentum.
Looking ahead, Estee Lauder expects innovation's contribution to sales to increase 200-250 basis points in fiscal 2027, led by skin care. Clinique and The Ordinary have introduced PDRN-based innovations, while the Estee Lauder brand has unveiled offerings focused on longevity and nighttime skin care. Clinique has also introduced a sensitive-skin franchise, while M·A·C has expanded its Signature lip franchise. New fragrance offerings from Balmain Beauty, KILIAN PARIS, Jo Malone London and TOM FORD further strengthen the pipeline.
This broader focus on innovation could help Estee Lauder attract new consumers, strengthen demand for its brands and support sales growth across categories. However, sustained growth will depend on how well these new products resonate with consumers and drive repeat purchases.
Estee Lauder’s Zacks Rank & Share Price PerformanceShares of this Zacks Rank #3 (Hold) company have gained 14.1% in the past three months against the broader Consumer Staples sector and the industry’s decline of 3.8% and 2.8%, respectively. EL has also outperformed the S&P 500 index’s growth of 3.3% during the same period.
EL Stock's Past Three Months Performance
Image Source: Zacks Investment Research
Is Estee Lauder a Value Play Stock?EL currently trades at a forward 12-month P/E ratio of 27.1 compared with the industry average of 23.28. This valuation places the stock at a premium relative to peers, indicating broader market expectations around its business stability and ability to navigate current cost and demand dynamics.
EL P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Stocks to Considere.l.f. Beauty, Inc. (ELF - Free Report) provides cosmetics and skin care products worldwide and currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for e.l.f. Beauty’s current fiscal-year sales and earnings calls for growth of 20.3% and 16.6%, respectively, from the year-ago reported numbers. ELF delivered a trailing four-quarter earnings surprise of 61.5%, on average.
Dollar Tree Inc. (DLTR - Free Report) is an operator of discount variety stores offering a broad assortment of everyday consumables and discretionary merchandise. The company currently carries a Zacks Rank #2 (Buy). DLTR delivered a trailing four-quarter earnings surprise of 12.2%, on average.
The Zacks Consensus Estimate for Dollar Tree’s current fiscal-year sales and earnings indicates growth of 6.6% and 36.4%, respectively, from the year-ago reported numbers.
Target Corporation (TGT - Free Report) operates as a general merchandise retailer in the United States. It currently carries a Zacks Rank of 2. TGT delivered a trailing four-quarter average earnings surprise of 10.5%.
The Zacks Consensus Estimate for Target’s current fiscal-year sales and earnings indicates growth of 5.1% and 37.8%, respectively, from the year-ago actuals.
Tržby Broadcomu z čipů pro AI ve třetím fiskálním čtvrtletí meziročně vzrostly o 221 % na 16,7 miliardy USD; ve čtvrtém čtvrtletí firma očekává tržby ve výši 21,7 miliardy USD.
A $10,000 stake in Broadcom a decade ago grew into a life-changing sum, but the company that delivered those gains barely resembles the one investors face today. Whether AI demand can fuel another historic run depends on factors Broadcom itself…
Over the past decade, Broadcom (NASDAQ:AVGO | AVGO Price Prediction) shares rose 2636.4%, from a split-adjusted $13.56 to $370.95 in premarket trading. That run turned a $10,000 stake into $273,640. The forecast model’s scenarios start from a price of $377.92.
Broadcom has become one of the main suppliers of custom AI chips, so the obvious question is what $10,000 invested now could be worth by 2031.
What $10,000 Could Become by 2031 In the base case, a $10,000 investment in Broadcom could be worth roughly $16,354 by 2031, representing a total return of 63.54%. The modeled five-year share price of $618.07 implies an annualized return of 10.34%. The model’s confidence score is 0.9, which it classifies as high.
So can the last decade repeat? Even the most optimistic outcome gets a $10,000 stake to $22,730, well short of a quarter-million dollars. Broadcom’s market cap is now about $1.79 trillion, and a company that large has a much harder time compounding at the pace it managed when it was smaller.
Bull, Base and Bear Scenarios for a $10,000 Stake Scenario (2031) Target Price Total Return Value of $10,000 Bull $859.01 127.3% $22,730 Base $618.07 63.54% $16,354 Bear $449.99 19.07% $11,907 The one-year projection extends through 2027. It points to $536.52 in the bull case ($14,197), $441.06 in the base case ($11,671) and $386.76 if conditions turn unfavorable ($10,234).
AI Chip Demand Driving the Forecast AI Revenue Is Accelerating Fiscal third-quarter AI semiconductor revenue was $16.7 billion, up 221% from a year earlier. Total revenue reached $29.59B, ahead of estimates, and non-GAAP EPS of $3.32 beat the $3.24 estimate. Management guided fourth-quarter AI revenue to $21.7 billion.
It also laid out AI semiconductor revenue of roughly $115 billion in fiscal 2027 and $230 billion in fiscal 2028. On the call, Hock Tan said Broadcom is “very much on target to exceed $30 in earnings per share in fiscal 2028.”
Large AI Labs Are Committing Management expects Anthropic to become Broadcom’s largest custom accelerator customer in 2027. OpenAI’s first-generation Jalapeno chip is on track for a 1.3 gigawatt deployment that year.
Tan said “Our demand actually exceeds this outlook and we will work to improve supply.” AI networking adds a second engine: Broadcom has taped out Tomahawk 7, which it calls the industry’s first 200-terabit-per-second Ethernet switch.
Wall Street Is Firmly Bullish Analysts rate the stock 7 Strong Buy, 40 Buy and 3 Hold, with no Sell ratings. Their consensus target of $531.31 is above the model’s base case for the next year.
Shares trade at 46x trailing earnings but only 19x forward earnings, so the price already assumes much of the expected growth.
Risks That Could Shrink Your $10,000 Supply could cap growth. Management named leading-edge wafers, substrates, HBM memory, power, land and data-center shells as constraints on how fast AI capacity gets deployed.
Tan put it plainly: “It’s a multidimensional issue to get an AI data center deployed.” Each of those bottlenecks is a business for someone else, and we rounded up seven suppliers riding the same buildout in a free report on the non-chipmaker AI winners.
Concentrated customer base: A small group of AI developers drives most of the expected demand. If one of them slows its spending, revenue could fall hard. Margin pressure: Gross margin slipped to 75%, down 210 basis points from the prior quarter, because custom chips carry more memory content. Balance sheet: Broadcom carries $59.6 billion of fixed-rate debt and may provide residual value guarantees tied to financing for AI labs. Volatility: With a beta of 1.476, the stock has traded between $288.95 and $493.28 over the past 52 weeks. Trade restrictions and the chip cycle add further risk. What to Watch Before 2031 The model puts a $10,000 Broadcom stake at between $11,907 and $22,730 by 2031, with $16,354 as the central estimate. That outcome would be solid, but it falls far short of the last decade’s gain.
The next checkpoint is the fiscal fourth-quarter earnings report scheduled for December 9, which should show whether AI revenue reaches its $21.7 billion guide. None of these outcomes is guaranteed; the figures are a projection, not investment advice.
Contact [email protected] for any questions or corrections.
Key Takeaways ADP shares gained 43.4% in three months, outpacing the industry's 30.4% growth, reflecting strong momentum.ADP expects 5-6% revenue growth in fiscal 2027, supported by HCM technology, AI integration & acquisitions.ADP generated $5.44B in fiscal 2026 operating cash flow, supporting dividends, buybacks & flexibility. Automatic Data Processing, Inc. (ADP - Free Report) has delivered impressive performance over the past six months and shows potential to sustain its near-term momentum. Therefore, if you have not yet taken advantage of the share price appreciation of this leading provider of cloud-based human capital management (HCM) technology solutions, you should add the stock to your portfolio.
What Makes ADP an Attractive Pick? An Outperformer: A glimpse at the company’s price trend reveals that the stock has had a decent run over the past six months. Shares of Automatic Data Processing have risen 43.4% compared with the 30.4% growth of the industry it belongs to.
Image Source: Zacks Investment Research
Solid Rank: ADP currently carries a Zacks Rank #2 (Buy). Our research shows that stocks with a Zacks Rank #1 (Strong Buy) or #2 offer attractive investment opportunities for investors.
Northward Estimate Revisions: Over the past 60 days, one earnings estimate for fiscal 2027 has moved northward, reflecting analysts’ confidence in the company. The Zacks Consensus Estimate for fiscal 2027 earnings has marginally increased during this period.
Positive Earnings Surprise: ADP has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in each of the trailing four quarters, delivering an earnings surprise of 2.1% on average.
Strong Growth Prospects: The Zacks Consensus Estimate for ADP’sfirst-quarter fiscal 2027 revenues is pegged at $5.47 billion, indicating a 5.6% increase from the year-ago quarter. For fiscal 2027, the consensus estimate is $23.25 billion, suggesting 6% year-over-year growth.
The consensus estimate for first-quarter earnings is pegged at $2.78 per share, indicating 11.7% year-over-year growth. For the full year, the consensus mark is pegged at $12.27 per share, implying 10.3% growth from the prior year.
Growth Factors:Strategic HCM Focus Supports Sustained Growth: Automatic Data Processing’s strategic priorities reinforce its competitive position as a global HCM and HR outsourcing provider. The company focuses on delivering best-in-class HCM technology, leveraging its expertise and outsourcing capabilities, and expanding its global scale. In fiscal 2026, revenues increased 7% to $21.9 billion, supported by 6% organic growth on a constant-currency basis. Management expects consolidated revenue growth of 5-6% in fiscal 2027. ADP’s focus on technology, outsourcing expertise and global reach should support client retention, deepen customer relationships and provide a foundation for sustained revenue growth.
AI Integration & Acquisitions Broaden Capabilities: ADP is leveraging artificial intelligence (AI) to improve productivity across products, services and sales. In fiscal 2026, ADP Assist handled 12 million conversations, while The Zone, ADP’s proprietary, AI-infused internal ecosystem and customer relationship management sales and service platform, reached 48% of service staff and helped reduce contacts per client by 4%. Management expects AI-driven efficiencies to support adjusted EPS growth in fiscal 2027. Strategic acquisitions have also expanded ADP’s HCM capabilities. WorkForce Software strengthened global workforce management, while Pequity added AI-enabled compensation planning tools. Growth in global time bookings in fiscal 2026 reflected adoption of WorkForce Software’s solution. These initiatives should improve efficiency, deepen client engagement and support long-term growth.
Healthy Cash Flow Supports Financial Flexibility: ADP’s cash generation and liquidity position support financial obligations and shareholder returns. At the end of the fourth quarter of fiscal 2026, cash and equivalents stood at $4.23 billion against long-term debt of $4.96 billion. Fiscal 2026 operating cash flow rose to $5.44 billion from $4.94 billion a year earlier, exceeding the year-end balance of long-term debt. The current ratio stood at 1.05, while commercial paper borrowings declined to zero from $4.77 billion in fiscal 2025. Continued cash generation and access to short-term funding should support ADP’s financial flexibility and capital allocation priorities.
Consistent Capital Returns Support Shareholder Value: ADP continues to reward shareholders through dividends and buybacks. Dividends paid rose to $2.63 billion in fiscal 2026 from $2.40 billion in fiscal 2025 and $2.18 billion in fiscal 2024. Share repurchases totaled $2.08 billion in fiscal 2026. Sustained cash generation should support future distributions while maintaining financial flexibility.
Other Stocks to ConsiderA couple of other top-ranked stocks in the broader Computer and Technology sector are Analog Devices, Inc. (ADI - Free Report) and Applied Materials, Inc. (AMAT - Free Report) .
Analog Devices sports a Zacks Rank #1 at present. It has a long-term earnings growth expectation of 25%. ADI delivered a trailing four-quarter earnings surprise of 4.8%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
Applied Materials also flaunts a Zacks Rank of 1 at present. It has a long-term earnings growth expectation of 28.1%. AMAT’s earnings beat estimates in each of the trailing four quarters, with the surprise being 5.5%, on average.
Analytici očekávají, že State Street ve 3. čtvrtletí zvýší zisk na 3,63 USD na akcii, což představuje meziroční nárůst o 30,6 %, při tržbách ve výši 4,04 mld. USD.
Analysts on Wall Street project that State Street Corporation (STT - Free Report) will announce quarterly earnings of $3.63 per share in its forthcoming report, representing an increase of 30.6% year over year. Revenues are projected to reach $4.04 billion, increasing 14% from the same quarter last year.
The current level reflects an upward revision of 0.6% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Given this perspective, it's time to examine the average forecasts of specific State Street metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Basel III Advanced Approaches - Tier 1 Leverage Ratio' will reach 5.3%. The estimate is in contrast to the year-ago figure of 5.6%.
The combined assessment of analysts suggests that 'Average balance - Total interest-earning assets' will likely reach $305.35 billion. Compared to the present estimate, the company reported $295.46 billion in the same quarter last year.
The consensus estimate for 'Basel III Standardized Approach - Tier 1 capital ratio' stands at 13.4%. The estimate is in contrast to the year-ago figure of 13.9%.
The average prediction of analysts places 'Assets under Management (AUM)' at $6375.31 billion. The estimate is in contrast to the year-ago figure of $5446.00 billion.
Analysts expect 'Net Interest Income' to come in at $857.91 million. The estimate is in contrast to the year-ago figure of $715.00 million.
Analysts forecast 'Total fee and other revenue' to reach $3.20 billion. Compared to the current estimate, the company reported $2.83 billion in the same quarter of the previous year.
According to the collective judgment of analysts, 'Net Interest Income - fully taxable-equivalent basis' should come in at $857.91 million. The estimate is in contrast to the year-ago figure of $716.00 million.
The collective assessment of analysts points to an estimated 'Software services' of $170.68 million. Compared to the current estimate, the company reported $227.00 million in the same quarter of the previous year.
The consensus among analysts is that 'Other fee revenue' will reach $112.65 million. The estimate is in contrast to the year-ago figure of $79.00 million.
Based on the collective assessment of analysts, 'Management fees' should arrive at $811.83 million. The estimate is in contrast to the year-ago figure of $612.00 million.
It is projected by analysts that the 'Servicing fees' will reach $1.52 billion. The estimate is in contrast to the year-ago figure of $1.36 billion.
Analysts' assessment points toward 'Foreign exchange trading services' reaching $443.37 million. The estimate compares to the year-ago value of $416.00 million.
View all Key Company Metrics for State Street here>>>
Shares of State Street have experienced a change of -8.5% in the past month compared to the +1.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), STT is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Devon Energy očekává čtvrtletní zisk ve výši 1,20 USD na akcii, což představuje meziroční nárůst o 15,4 %; konsenzuální odhad se za posledních 30 dní zvýšil o 5,7 %.
Devon Energy (DVN - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this oil and gas exploration company have returned -2.2%, compared to the Zacks S&P 500 composite's +1.3% change. During this period, the Zacks Oil and Gas - Exploration and Production - United States industry, which Devon Energy falls in, has lost 2.6%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, Devon Energy is expected to post earnings of $1.20 per share, indicating a change of +15.4% from the year-ago quarter. The Zacks Consensus Estimate has changed +5.7% over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $5.35 points to a change of +36.5% from the prior year. Over the last 30 days, this estimate has changed +2.1%.
For the next fiscal year, the consensus earnings estimate of $5.28 indicates a change of -1.3% from what Devon Energy is expected to report a year ago. Over the past month, the estimate has changed +4.8%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Devon Energy.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of Devon Energy, the consensus sales estimate of $7.3 billion for the current quarter points to a year-over-year change of +68.5%. The $25.96 billion and $28.03 billion estimates for the current and next fiscal years indicate changes of +51% and +8%, respectively.
Last Reported Results and Surprise HistoryDevon Energy reported revenues of $7.42 billion in the last reported quarter, representing a year-over-year change of +73.1%. EPS of $1.57 for the same period compares with $0.84 a year ago.
Compared to the Zacks Consensus Estimate of $6.3 billion, the reported revenues represent a surprise of +17.76%. The EPS surprise was +20.77%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Devon Energy is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Devon Energy. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Mondelez rozšiřuje nabídku Biscoff v Evropě a Indii; čokoláda Marabou Biscoff získala během několika týdnů přibližně 7% podíl na švédském trhu čokoládových tabulek.
Key Takeaways Mondelez is expanding Biscoff across biscuits and chocolate, driven by innovation in Europe and India. Marabou Biscoff captured nearly 7% of Sweden's chocolate tablet market within weeks of its launch. Biscoff's India launch is exceeding projections, while Mondelez boosts investments to drive consumer trials. Mondelez International, Inc. (MDLZ - Free Report) is expanding Biscoff's international presence through product innovation, new launches and brand investments. The company's efforts to develop Biscoff offerings across biscuits and chocolate are showing encouraging progress, particularly in Europe and India. Recent launches highlight Mondelez's focus on broadening the brand's reach across product categories and geographic markets.
In Europe, the Biscoff chocolate platform continues to deliver strong year-over-year growth, supported by new product introductions. Marabou Biscoff has emerged as a notable launch, capturing approximately 7% market share in Sweden's chocolate tablet segment within weeks of introduction. This early performance reflects encouraging consumer acceptance of Biscoff-related chocolate innovation in the region.
India represents another important market for Biscoff's expansion. The Biscoff biscuit launch, alongside Cadbury Milkinis, is contributing significantly to Mondelez's growth, with both performing ahead of internal projections. The encouraging initial performance highlights the progress of new product introductions in India, where Biscoff forms part of the company's broader innovation efforts.
Mondelez is also stepping up brand investments to support Biscoff's development. In Europe, the company is increasing its focus on demand-creation activities aimed at encouraging consumers to try Biscoff products. These initiatives complement ongoing innovation efforts and support the company's focus on strengthening consumer engagement with the brand.
Overall, Biscoff's expansion across biscuits and chocolate is gaining traction in international markets. Strong growth in Europe's chocolate platform, early market share gains in Sweden and encouraging launches in India demonstrate progress. Sustaining this momentum through continued innovation and consumer trials remains central to Mondelez's efforts to establish Biscoff as a broader global growth platform.
MDLZ Stock Price Performance, Valuation & EstimatesShares of the Zacks Rank #2 (Buy) company have rallied 12.7% year to date against the industry’s decline of 6.1%.
MDLZ Price Performance Versus Industry
Image Source: Zacks Investment Research
From a valuation standpoint, MDLZ trades at a forward price-to-earnings ratio of 18.35, above the industry’s average of 13.54.
MDLZ Valuation Compared to Industry
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MDLZ’s current and next fiscal-year earnings per share implies year-over-year growth of 4.5% and 10.8%, respectively.
Other Stocks to ConsiderThe Chefs' Warehouse, Inc. (CHEF - Free Report) , a premier distributor of specialty food products currently carries a Zacks Rank #1 (Strong Buy). CHEF delivered a trailing four-quarter earnings surprise of 30.4%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for The Chefs' Warehouse’s current fiscal-year sales and earnings per share (EPS) implies growth of 10.8% and 33.7%, respectively, from the year-ago figures.
Mama's Creations, Inc. (MAMA - Free Report) , a prepared-foods company focused on fresh, ready-to-eat and deli products, currently carries a Zacks Rank of 2. MAMA delivered a trailing four-quarter surprise of 121.7%, on average.
The Zacks Consensus Estimate for Mama's Creations’ current fiscal-year sales and EPS indicates respective increases of 30.3% and 66.7% from the year-ago period.
Laird Superfood, Inc. (LSF - Free Report) , a consumer product company that develops, manufactures and markets plant-based, natural and functional food and beverage products, currently carries a Zacks Rank #2. LSF delivered an earnings surprise of 100% in the last reported quarter.
The Zacks Consensus Estimate for Laird Superfood’s current fiscal-year sales and EPS implies growth of 188.2% and 104%, respectively, from the year-ago figures.
Rivian ve spolupráci s Ghostbusters zpřístupnil halloweenské funkce pro modely R1S, R1T a R2. Ve třetím čtvrtletí dodal 19 248 vozů, oproti 13 201 vozům ve stejném období loňského roku.
Electric vehicle company Rivian Automotive (NASDAQ:RIVN) recently launched the new R2 SUV, the company’s cheapest model to date. The R2 and other Rivian vehicles got the spotlight for the Halloween season thanks to a collaboration with one of the most well-known supernatural movie franchises of all-time.
• Rivian Automotive stock is under selling pressure. What’s driving RIVN stock lower?
Rivian Partners with GhostbustersRivian continues its annual tradition of adding Halloween-themed features to its vehicles for owners. This year’s Halloween features center on the hit "Ghostbusters" film franchise.
Software updates include an immersive Ghostbusters experience, a scavenger hunt, lights and sounds from the films and more. The features are available for the R1S, R1T and R2 and are available from Oct. 9 through Nov. 2.
The collaboration with Sony Pictures, which is a unit of Sony Group Corp (NYSE:SONY), includes a one-off customized Ecto-1 Rivian vehicle and a commercial that features original "Ghostbusters" actor Bill Murray once again portraying the iconic role of Dr. Peter Venkman and hunting ghosts in the Rivian EV.
The commercial, which can be viewed below, also features the iconic "Ghostbusters" theme song from Ray Parker Jr.
Read Next
Will the Collaboration Pay Off?When it comes to celebrity endorsements, Murray may not jump off the page as a top billing. This is, of course, less about Murray as an endorsee and more about the fun Halloween features for the Rivian vehicles.
The commercial and collaboration could show more consumers the annual tradition of Rivian adding Halloween features. While this likely isn’t a game changer or a full reason to buy the EV, it shows Rivian is focused on fun and connecting with consumers.
Rivian recently reported third-quarter deliveries of 19,248 vehicles. That figure was up from 13,201 in the prior year and also higher than the 12,194 and 10,365 vehicles delivered in the second and first quarters of this year, respectively.
The EV company expects 65,000 to 75,000 deliveries this year, which implies 23,193 to 33,193 vehicles delivered in the fourth quarter.
A "Ghostbusters" collaboration may not seem like much, but it could keep momentum going on an already strong year for Rivian.
Rivian will report third-quarter financial results Oct. 29. Analysts expect the company to report record revenue of $1.97 billion, according to data from Benzinga Pro.
The company has beaten analyst estimates for revenue in seven straight quarters and in nine of the last 10 quarters overall.
Generální ředitel společnosti Robinhood Vladimir Tenev 5. října prodal 375 000 akcií třídy A za 42,6 milionu USD, nadále však drží 47,4 milionu akcií třídy B.
A CEO’s stockholding can fall to zero without signaling a loss of faith in his company. Robinhood Markets, Inc. (NASDAQ:HOOD) CEO Vladimir Tenev sold $42.6 million worth of shares, leaving him with no directly held Class A stock — but the SEC filing reveals a crucial distinction between the shares he sold and the ownership he still retains.
The $42 Million SaleTenev sold 375,000 shares on Oct. 5 at a weighted-average price of approximately $113.72, according to his Form 4 filing with the Securities and Exchange Commission, filed Oct. 7. The transaction generated approximately $42.6 million.
The headline-grabbing detail is that Tenev’s directly held Class A share balance fell to zero following the sale. But the filing shows he still directly held 47.4 million Class B shares, along with 6,907 Class A shares held indirectly through a living trust.
That distinction matters because Robinhood has a dual-class share structure. Its Class B shares carry greater voting power than Class A shares, giving holders of the former more influence over corporate decisions relative to their economic ownership. Tenev’s sale therefore reduced his directly held Class A position without eliminating his broader stake in the company.
Read Next
The Fine Print Changes the StoryThe transaction also wasn’t an entirely new decision made on the day the shares were sold. Tenev’s Form 4 states that the sale was executed under a Rule 10b5-1 trading plan adopted on Sept. 5, 2025.
These plans allow corporate insiders to schedule stock transactions in advance under predetermined instructions, helping separate trading decisions from access to potentially material nonpublic information. They don’t automatically signal a bullish or bearish sale, but the timing and terms provide important context for investors interpreting insider activity.
Tenev’s latest transaction also follows earlier sales under the same plan, according to previous SEC filings. The pattern makes it more useful to examine the planned schedule and remaining holdings than to treat the latest sale as an isolated verdict on Robinhood’s prospects.
Read Next
What HOOD Investors Should WatchInsider selling can reflect diversification, liquidity needs or other personal financial considerations. Without further evidence, the transaction alone does not establish that Tenev expects Robinhood shares to fall. Equally, a prearranged plan does not make the sale irrelevant: investors can still track the pace of insider disposals and changes in executives’ ownership.
For HOOD shareholders, the more meaningful signals remain Robinhood’s trading activity, customer growth, product expansion and ability to generate revenue across market cycles. Tenev has converted a portion of his holdings into cash, but the filing does not show him abandoning his ownership position.
Investors should distinguish between a large headline number and a genuine change in an executive’s economic exposure before drawing conclusions about the stock.
Read Next
Photo courtesy: Thrive Studios ID / Shutterstock.com
Veeva Systems ve druhém čtvrtletí fiskálního roku 2027 překonala odhady zisku i tržeb a zvýšila celoroční výhled. Vault CRM využívá přes 180 zákazníků.
Key Takeaways Veeva Systems beat Q2 estimates, raised its fiscal 2027 outlook and advanced Vault CRM adoption.VEEV has more than 180 Vault CRM customers live, with commitments from 12 of the top 20 biopharmas.Veeva Systems' AI push is advancing, but market saturation and competition could constrain CRM growth. Veeva Systems Inc. (VEEV - Free Report) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid second-quarter fiscal 2027 performance and CRM migrations, is expected to contribute further. However, market saturation remains a cause for concern.
This Zacks Rank #3 (Hold) company’s shares have gained 27.6% in the year-to-date period compared with 15.8% growth of the industry. The S&P 500 composite has increased 14.5% during the said time frame.
The renowned provider of cloud-based software applications and data solutions for the life sciences industry has a market capitalization of $45.74 billion. The company anticipates 35% growth for the next five years and expects to maintain its strong performance in the future. It delivered a trailing four-quarter average earnings surprise of 5.7%.
Image Source: Zacks Investment Research
Reasons Favoring VEEV’s GrowthEnterprise CRM Migrations Expanding Account Footprint: Vault CRM adoption continued to advance in the second quarter of fiscal 2027, when Veeva Systems recorded its best CRM quarter and added two top-20 biopharma selections. Management said that Veeva Systems now has 12 of the top 20 CRM commitments, with two decisions remaining, up from 10 wins in the prior quarter.
More than 180 customers are live on Vault CRM, and one top-20 customer has enabled AI across its full field force. Commercial subscription revenues rose 13% year over year to $347.4 million, with management citing growth across CRM, content, data, Crossix and Ostro. The expanding live base supports ongoing migrations and creates opportunities to attach adjacent commercial applications as customers consolidate workflows on Vault.
Diversified Platform Driving Durable Growth:Veeva Systems’ long-term growth story is increasingly tied to its position at the center of life sciences digital transformation. The company operates across a broad set of markets spanning clinical development, quality management, regulatory operations, safety, commercial engagement and data analytics. Veeva Systems’ Development Cloud portfolio is particularly well-positioned as pharmaceutical companies seek integrated platforms that connect clinical data, trial operations, quality processes and regulatory functions within a unified ecosystem.
Growth is being fueled by newer product areas that remain in the early stages of penetration, including clinical data management, randomization and trial supply management, drug safety and laboratory information management systems. Management believes these businesses have a significant runway as customers increasingly favor end-to-end platforms over fragmented point solutions.
Strong Q2 Results: VEEV delivered better-than-expected second-quarter fiscal 2027 results, with both earnings and revenues surpassing the Zacks Consensus Estimate. The company also raised its full-year outlook, supported by solid execution across Commercial Solutions and R&D and Quality Solutions. Vault CRM continued to gain traction, achieving a record quarter with more than 180 customers live, including five of the top 20 biopharma companies. Two additional top 20 biopharmas and one large enterprise biopharma committed to the platform in August, bringing total top 20 commitments to 12 globally. A leading biopharma also deployed Vault CRM and Agentic Call Report across its entire U.S. field team, highlighting growing enterprise adoption.
Veeva Systems also advanced its artificial intelligence initiatives, with Veeva Falcon, its agentic labor platform for clinical, regulatory and safety functions, attracting five early adopters and remaining on track for initial go-lives in 2026. The acquisition of Copli and launch of Veeva Falcon MLR further strengthen the company's capabilities in automating content reviews. Meanwhile, Vault AI expanded its standard agent offerings and introduced advanced tools for custom agent development.
Although strong customer interest in Falcon presents a potential growth opportunity, product readiness and successful early-adopter deployments remain key near-term priorities. Overall, continued CRM adoption and AI-driven innovation could support Veeva Systems' long-term growth, although the commercial impact of newer offerings will depend on execution and broader customer adoption.
Factor That May Offset VEEV’s GainsMarket Saturation: The life sciences industry, Veeva Systems' primary market for its CRM solutions, is facing increasing saturation as digital transformation and CRM adoption have become widespread across pharmaceutical and biotech companies. Many large enterprises have already implemented Veeva Systems' CRM software or similar solutions, leaving fewer untapped opportunities for new customer acquisition.
Additionally, as smaller biotech firms and generics manufacturers enter the market, they may seek more cost-effective or niche CRM alternatives rather than Veeva Systems' premium offerings. This saturation, combined with heightened competition from both traditional CRM providers and emerging AI-powered platforms, could limit Veeva Systems' ability to maintain its historical CRM sales growth rates.
Estimate TrendVeeva Systems is witnessing a stable estimate revision trend for fiscal 2027. In the past 30 days, the Zacks Consensus Estimate for fiscal 2027 earnings per share (EPS) has remained stable at $9.22.
The Zacks Consensus Estimate for third-quarter fiscal 2027 revenues is pegged at $933.8 million, indicating a 15.1% improvement from the year-ago quarter’s reported number. The consensus mark for fiscal third-quarter EPS is pegged at $2.33, implying a 14.2% improvement year over year.
Key PicksSome better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , Veracyte (VCYT - Free Report) and West Pharmaceutical (WST - Free Report) .
Globus Medical, currently sporting a Zacks Rank #1 (Strong Buy), reported a second-quarter 2026 adjusted EPS of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 27.9%.
Veracyte, currently flaunting a Zacks Rank #1, reported a second-quarter 2026 adjusted EPS of 54 cents, which surpassed the Zacks Consensus Estimate by 25.6%. Revenues of $150.3 million beat the Zacks Consensus Estimate by 4.1%.
VCYT has an estimated earnings growth rate of 8.4% for 2026. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 41.8%.
West Pharmaceutical, carrying a Zacks Rank #2 (Buy) at present, reported second-quarter 2026 adjusted EPS of $2.37, which beat the Zacks Consensus Estimate by 13.9%. Revenues of $872.3 million surpassed the Zacks Consensus Estimate by 4.2%.
WST has an estimated long-term earnings growth rate of 16%. West Pharmaceutical’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 17.4%.
IonQ dosáhla rychlosti více než 1 000 kvantových provázání za sekundu mezi iontovým qubitem a polovodičovou pamětí, tedy více než čtyřnásobku předchozího rekordu u uvězněných iontů.
Photonic interconnect generates more than 1,000 quantum connections per second between a trapped ion qubit and a silicon vacancy quantum memory.That entanglement rate is fast enough to support distributed quantum computing and other use cases. COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world’s leading full-stack quantum platform and foundry, today announced the achievement of entanglement rates above 1,000 per second (1 kHz) between a trapped ion qubit and a solid-state memory, through a photonic interconnect. Entanglement is the quantum connection that lets separate systems work together, and it is the essential ingredient for networking quantum computers. While the trapped ion qubit sets the standard for qubit coherence, the solid-state quantum memory has unmatched efficiency coupling to light. Their juxtaposition is the best of both worlds, demonstrating the fastest quantum interconnect rate between qubits of any platform.
“IonQ has crossed a pivotal milestone for memory enhanced quantum interconnects, achieving more than 1,000 entanglement events per second,” said Niccolo de Masi, Chairman and CEO of IonQ. “Classical data centers achieved massive scale by connecting specialized processors, memory, and networks. Quantum systems will scale in much the same way. This breakthrough addresses a critical interconnect bottleneck and advances IonQ’s roadmap to build the networked quantum data centers of the future.”
A technical paper presents results from real-world hardware testing of an end-to-end link between a trapped ion system and a silicon vacancy (SiV) qubit, building on IonQ’s SiV quantum memory platform. IonQ’s demonstration achieves rates more than four times faster than the previous record1 for trapped ions, held by IonQ co-founder Chris Monroe’s research group at Duke University, also a collaborator on the paper.
“IonQ’s efforts in quantum interconnects go back over a decade, to the founding of the company. Moving qubits through photons will be necessary in any large-scale quantum computer, and this demonstration sets the foundation for some amazing work to come,” said Monroe, Chief Scientist at IonQ and Gilhuly Family Presidential Distinguished Professor at Duke University.
“This work shows that a photonic quantum interconnect need not be a bottleneck for distributed quantum computing,” said Mihir Bhaskar, IonQ SVP and GM of Quantum Technologies at SkyWater. “Our technology can interface with almost any qubit type, so we see this unlocking a wide range of opportunities across multiple hardware modalities, from modular computing to networked sensing and beyond.”
This quantum memory and interconnect approach is also driving IonQ’s work with the Defense Advanced Research Projects Agency’s (DARPA) HARQ program, which seeks to develop high-speed quantum interconnects compatible with multiple computing qubit types. While this latest demonstration used trapped ion systems, the underlying architecture is expected to be compatible with multiple qubit approaches. This may include neutral atoms and superconducting systems with transducers (devices that convert microwave signals into light).
IonQ’s memory and interconnect platform is likewise ramping up commercially, with the first commercial sale to the University of Maryland announced in April, and a second system sale to SDT in South Korea, announced in September.
Additional technical details can be found in the arXiv preprint.
About IonQ
IonQ, Inc. [NYSE: IONQ] is the world’s leading quantum platform and foundry - delivering integrated quantum solutions across computing, networking, sensing, and security. IonQ’s newest generation of quantum computers, the Superion, is the latest in a line of cutting-edge systems. Earlier systems have helped customers and partners including Amazon Web Services, AstraZeneca, and NVIDIA achieve a 20x performance increase over previous quantum solutions and accelerate innovation in drug discovery, materials science, financial modeling, logistics, cybersecurity, and defense. In 2025, the company achieved 99.99% two-qubit gate fidelity, setting a world record in quantum computing performance.
Headquartered in College Park, Maryland, IonQ has operations across North America, Latin America, EMEA, and APAC. Our quantum computing services have been available through all major cloud providers since 2021, while we also meet the needs of networking and sensing customers across land, sea, air, and space. IonQ is making quantum platforms more accessible and impactful than ever before. Learn more at IonQ.com.
IonQ Forward-Looking Statements
This press release contains forward-looking statements. All statements contained in this press release other than statements of historical fact are forward-looking statements, including statements regarding our research findings and their future applications, including in defense, critical infrastructure and environmental monitoring. In some cases, you can identify these statements by forward-looking words such as “pending,” “look forward,” “accelerate,” “anticipate,” “expect,” “suggest,” “plan,” “believe,” “intend,” “estimate,” “target,” “project,” “should,” “could,” “would,” “may,” “will,” “forecast,” “confident,” “position,” “become,” “on track,” “ensure,” “ongoing” and other similar expressions. These statements are only predictions based on our expectations and projections about future events as of the date of this press release and are subject to a number of risks, uncertainties and assumptions that may prove incorrect, any of which could cause actual results to differ materially from those expressed or implied by such statements, including, among others, those described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission, or SEC, and in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 to be filed with the SEC. New risks emerge from time to time, and it is not possible for our management to predict all risks, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement we make. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. Except as otherwise required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
References:
O’Reilly et al., Phys. Rev. Lett. 133, 090802 (2024) More News From IonQ
Openreach zavádí platformu Waveserver společnosti Ciena s technologií WaveLogic 6 s přenosovou rychlostí 1,6 Tb/s pro vysokokapacitní velkoobchodní síťové služby po celé Velké Británii.
Key Takeaways Ciena is deploying its Waveserver platform with Openreach to expand wholesale network services across the U.K.Its WaveLogic 6 combines 400G & 800G traffic, enabling national 800G services and future speed upgrades.AI, cloud adoption, online content and subsea traffic drive demand. Ciena Corporation (CIEN - Free Report) is strengthening its position in the optical networking market as rising demand for high-capacity connectivity drives investments in digital infrastructure. Its latest deployment with Openreach, a major U.K. telecommunications network provider, highlights an opportunity to capitalize on growing bandwidth requirements across data centers, telecommunications networks and international subsea connections.
Openreach is deploying Ciena’s Waveserver platform, powered by WaveLogic 6 (WL6) 1.6Tb/s coherent technology, as part of its Optical Spectrum Extended Access (OSEA) portfolio. The solution will enable Openreach to offer wholesale customers tailored, high-capacity network services across the U.K., including connectivity for cable landing stations, data centers and core network nodes. The deployment combines 400G and 800G client traffic over dedicated 1.6Tb/s wavelengths, with a compact 2RU chassis supporting up to 32 400G services. It enables Openreach to introduce national 800G services while providing a pathway to even higher speeds as bandwidth requirements increase. These capabilities could strengthen demand for Ciena’s optical networking solutions as network operators seek to transfer larger volumes of data efficiently.
As AI applications increase the need for high-bandwidth connections between data centers and other network endpoints, Ciena’s optical technology can help network operators accommodate rising traffic while scaling capacity to meet evolving requirements. Beyond AI, growing online content consumption, cloud adoption and international subsea traffic provide additional demand drivers. These applications broaden the potential market for Ciena’s solutions and underscore the importance of upgrading optical networks.
Despite favorable industry trends, Ciena faces competition from other optical networking vendors like Corning Incorporated (GLW - Free Report) and Nokia (NOK - Free Report) , targeting telecommunications operators and data center customers.
CIEN’s Market Position Faces Competitive PressureGLW entered the second half of 2026 with its growth outlook tied to AI infrastructure and optical connectivity. Corning is also expanding its GenAI optical portfolio with multicore fiber and high-density connectivity solutions that improve network capacity and reduce installation complexity. It announced a long-term partnership with NVIDIA to expand U.S.-based optical connectivity manufacturing capacity by 10 times and increase domestic fiber production capacity by more than 50%. In September, Corning secured a multi-year, multibillion-dollar Verizon deal to supply more than 80 million miles of optical fiber through 2032, boosting revenue visibility and exposure to broadband and AI infrastructure demand.
NOK continues to benefit from its broad portfolio spanning mobile networks, optical transport, IP routing, fixed broadband, software and services. Network Infrastructure delivered double-digit growth in second-quarter 2026, supported by continued momentum in Optical Networks and IP Networks. The planned divestiture of the Fixed Wireless Access CPE business simplifies the portfolio and allows greater investment in higher-growth opportunities such as AI networking and optical technologies. NOK is also expanding U.S. optical manufacturing capacity through investments in San Jose, PA and the planned acquisition of an additional semiconductor manufacturing site in Arizona. Management noted that supply constraints persist in optical networking, supporting long-term customer orders.
CIEN Price Performance, Valuation and EstimatesShares of CIEN have gained 27.3% in the past month compared with the Communications - Components industry’s surge of 14.8%.
Image Source: Zacks Investment Research
CIEN trades at a forward 12-month price-to-earnings (P/E) ratio of 42.07, above the industry’s 39.18.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CIEN’s earnings for fiscal 2026 has been revised upward over the past 60 days.
Image Source: Zacks Investment Research
Ciena currently has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Comcast (CMCSA - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this cable provider have returned -15.7%, compared to the Zacks S&P 500 composite's +1.3% change. During this period, the Zacks Cable Television industry, which Comcast falls in, has lost 19.7%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Comcast is expected to post earnings of $0.98 per share for the current quarter, representing a year-over-year change of -12.5%. Over the last 30 days, the Zacks Consensus Estimate has changed -4.1%.
The consensus earnings estimate of $3.49 for the current fiscal year indicates a year-over-year change of -19%. This estimate has changed -0.8% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $3.61 indicates a change of +3.6% from what Comcast is expected to report a year ago. Over the past month, the estimate has changed -2.2%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for Comcast.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
In the case of Comcast, the consensus sales estimate of $29.35 billion for the current quarter points to a year-over-year change of -5.9%. The $120.18 billion and $117.59 billion estimates for the current and next fiscal years indicate changes of -2.9% and -2.2%, respectively.
Last Reported Results and Surprise HistoryComcast reported revenues of $29.94 billion in the last reported quarter, representing a year-over-year change of -1.2%. EPS of $1.04 for the same period compares with $1.25 a year ago.
Compared to the Zacks Consensus Estimate of $29.18 billion, the reported revenues represent a surprise of +2.62%. The EPS surprise was +7.22%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Comcast is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Comcast. However, its Zacks Rank #4 does suggest that it may underperform the broader market in the near term.
SummaryBlackstone Secured Lending Fund is rated HOLD, with a strong bias to upgrade after a likely dividend reset.BXSL’s first dividend shortfall in 28 quarters signals an imminent payout cut, already telegraphed by management in consecutive quarters.Credit quality is stabilizing: non-accruals fell to 1.8% of fair value, and the balance sheet remains robust with $2.8B liquidity.At 0.92× NAV, BXSL trades near historical lows, pricing in credit stress but not fully reflecting the upcoming dividend reduction.Looking for more investing ideas like this one? Get them exclusively at iREIT®+HOYA Capital. Learn More » Richard Drury/DigitalVision via Getty Images
Investment Thesis and Recommendation Blackstone Secured Lending Fund (BXSL) is owned for two things: a conservative senior-secured book and one of the higher current yields among the large-cap direct lenders, historically paid from a wide
5.8K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of ARCC, BXSL, HTGC, TSLX, MSDL, RWAYI, MSIF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
The content of this article reflects my personal views and is provided for informational and educational purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy or sell any securities or financial instruments. While I strive for accuracy, the information presented may contain errors or omissions or be based on sources believed to be reliable but not independently verified. I make no representations or warranties as to the completeness, accuracy, or timeliness of any information presented. This article is not intended to provide, and should not be relied upon for, investment, legal, tax, or accounting advice. The securities and strategies discussed may not be suitable for all investors. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal. I may hold, or have held, positions in the securities mentioned. I do not receive compensation for writing this article, nor do I intend to influence the price or trading volume of any security discussed. All opinions are subject to change without notice. This content is written strictly in a personal capacity and does not reflect the views of any employer, organization, or associated entity. Readers are strongly encouraged to conduct their own independent research and to consult with a licensed financial advisor before making any investment.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Citi zvýšila cílovou cenu společnosti CRISPR Therapeutics na 88 USD, což představuje potenciál růstu o 60 % díky rostoucí poptávce po genové terapii Casgevy.
It's been a disappointing past few years for patient shareholders of CRISPR Therapeutics (CRSP +4.87%). Despite the company passing multiple major milestones during this stretch, this biopharma/biotechnology stock's gone nowhere since falling back from its early 2021 peak.
Namely, in late 2023, the U.S. Food and Drug Administration approved CRISPR's Casgevy as a treatment for sickle cell disease, making it one of the nation's very first gene-editing-based therapies approved for any use. Patient uptake began shortly thereafter.
Premium Feature
Moneyball Superscore
56/100
Today's Change
(
4.87
%) $
2.46
Current Price
$
52.90
Analysts aren't deterred though, including Citi's Yigal Nochomovitz, who recently raised his price target on CRSPR from $82 to $88 per share on growing demand for the aforementioned Casgevy. That's 60% above the stock's present price.
The thing is, what needs to happen to pump this stock's price up to that lofty level is certainly possible. Here's a closer look.
It's in the name CRISPR Therapeutics' claim to fame -- as well as its drug pipeline and portfolio -- is rooted in the ability to repair damaged DNA by replacing it with a correct sequence of genetic information -- a discovery for which co-founder Emmanuelle Charpentier was awarded a Nobel Prize in Chemistry in 2020.
The underlying science is in the name, in fact. CRISPR -- an acronym for "clustered regularly interspaced short palindromic repeats" -- is a genetic sequence that can be identified and then spliced into by an RNA-guided DNA endonuclease protein called Cas9, allowing for the replacement of faulty genetic code in a strand of DNA.
Although the company's initial target was the relatively low-hanging fruit of sickle cell disease, the idea holds promise as a treatment for any number of genetics-driven disease. To this end, the company is working on several other therapies.
Right now, however, the market's pricing CRSPR shares based on a relatively small but important number of inputs.
Three things that must go right for Citi's CRISPR Therapeutics price target It's not all that matters, to be clear. But, for the time being anyway, investors are expectantly looking at these three factors.
1. Reported Casgevy revenue must be satisfactory CRISPR Therapeutics hasn't reported much Casgevy revenue yet, but it is accruing. It's just going to take time for it to make it to the company's top line in earnest. That's because Casgevy treatments are complex, and it can take a long while to administer and complete a treatment regimen.
Indeed, since each patient's treatment is custom-created from a sample of their own blood, it can take up to a year to deliver the final dosing administered at an authorized treatment center operated by CRISPR Therapeutics' treatment partner, Vertex Pharmaceuticals (VRTX +0.82%). Never even mind the length of time it might take an insurer to authorize the $2.2 million cost per Casgevy treatment. And even beyond that, any payments and insurance reimbursements are first processed by Vertex, which takes a cut.
Meaningful revenue is coming, though. In its second-quarter investor update posted in early August, CRISPR Therapeutics confirmed that the custom-created drug generated $76 million in total revenue over three months, a chunk of which is eventually headed to CRISPR's actual top line.
The exact amounts and time frames are still in question; both are moving targets. For what it's worth, though, the analyst community is looking for this year's collaboration and grant-led top line of $40.8 million to soar to $156.6 million next year, once Casgevy is finally driving real, tangible revenue for the company. Anything that puts the company anywhere on track for anything near that projected 2027 number will be just fine.
2. Encouraging progress from CTX310 Casgevy isn't the only drug under CRISPR's umbrella, even if it's the only one approved and on the market right now. CTX340 is a promising answer to refractory hypertension, for instance, while CTX460 showed efficacy as a potential treatment for problematic liver proteins, a condition known as alpha-1 antitrypsin deficiency, or AATD.
Image source: Getty Images.
Perhaps the one drug currently in the company's developmental pipeline with the potential to really move the needle, though, is CTX310, for the treatment of the cardiovascular disease linked to liver-made proteins that help regulate blood lipid levels. Using the same gene-editing science that helped create Casgevy, CRISPR Therapeutics hopes the treatment will help reduce patients' genetically high cholesterol.
Although no specific update date has been set, CRISPR reported in August that it expects to post an update of CTX310's phase 1 clinical trials currently underway sometime before the end of the year. Given the obvious need for such a treatment (the global lipid-lowering drug market will be worth nearly $50 billion per year by 2035, according to Precedence Research), encouraging developmental progress on this front could help drive shares toward Citi's recently raised price target.
3. Proving a drug like zugo-cel can work Finally, while an update on CTX310's progress could help make or break CRSPR stock in the foreseeable future, it's not the only drug in CRISPR Therapeutics' pipeline with the potential to spark bullish interest in this ticker. A chimeric antigen receptor T-cell-based investigational cancer therapy called zugocabtagene geleucel -- or Zugo-cel, for short (formerly CTX112) -- is a prospective game changer for the company as well. Just not for the reason you might think.
While effective oncology drugs' value is clear, that's not what makes zugo-cel so interesting. Rather, what merits attention here is the fact that this therapy is an allogeneic treatment. That just means while it's technically a gene-editing drug, it doesn't require a patient-specific sample to create a custom-built therapy. It simply needs a healthy starting sample from anyone to turn into a medicine that can be administered to everyone. This simpler process costs dramatically less to utilize than Casgevy's patient-specific treatment approach.
It's not just for cancer either. Although the company's using zugo-cel to address hematologic malignancies, it may hold even more promise as a treatment for a range of autoimmune diseases, including lupus, anemia, and systemic sclerosis.
The resulting upshot for the stock will largely depend on how well the market understands this allogeneic gene therapy approach is more flexible and cost-effective than Casgevy's ex-vivo approach that requires the extraction of a specific patient's stem cells.
Conagra Brands snížila čtvrtletní dividendu na polovinu, na 17,5 centů; její udržitelnost závisí na obnovení růstu objemu prodejů, který v 1. čtvrtletí meziročně klesl o 2,1 %.
Conagra already cut its dividend in half and shares have lost nearly 60% over five years, yet income investors keep buying the yield. Whether that payout survives comes down to a single metric that management admits is still moving in…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Conagra Brands (NYSE:CAG | CAG Price Prediction) has already cut its dividend in half. Shares trade at $13.57 as of Thursday’s close, down 27.47% over the past year. Income investors now have to decide whether the smaller payout sits on solid ground or whether the pressure that forced the first cut is still building. A high yield only holds up as long as the company can keep paying it, and Conagra’s ability to keep paying depends on one thing: getting volume growing again.
Here’s a simple dividend safety check: A payout is sustainable when earnings and free cash flow cover it well and the company isn’t borrowing to fund it.
A Halved Payout That Still Screens as High Yield The quarterly dividend fell from 35 cents to 17.5 cents starting with the July 30 ex-dividend date. The latest declaration kept it at that level. That works out to a forward annual payout of 70 cents, or a forward yield of about 5.28% at today’s price. Stock screeners show something different. The trailing yield is 9.29%, based on $1.225 in trailing payments, and much of that money came at the old rate. Anyone shopping by trailing yield is looking at a payout that no longer exists.
The appeal is easy to see. Conagra owns familiar brands like Birds Eye, Duncan Hines, Healthy Choice, Marie Callender’s, Reddi-wip and Slim Jim, and its dividend history runs back to 1999 in the records.
Why the Yield Rose: A Falling Share Price Did the Work The quarterly payout held at 35 cents from mid-2023 through April 2026, so the yield climbed because the stock kept falling: $18.22 on Oct. 1, 2025, $17.19 on Dec. 19, 2025, $15.62 on April 1 and $14.01 on Sept. 30. Shares have lost 11.07% in the past month alone and 59.76% over five years. The slide was sharp enough to trigger a $968 million non-cash goodwill and brand impairment in fiscal Q2 2026.
Coverage Looks Fine in Earnings and Weak in Cash Conagra is an ordinary corporate, so adjusted EPS is the right measure of coverage. On that basis, the new 70-cent payout uses about 47% to 50% of fiscal 2027 adjusted EPS guidance of $1.40 to $1.50. The old rate would have used 93% to 100%, which explains why it was cut. Guidance itself is falling, down from roughly $1.70 in fiscal 2026. GAAP results look worse, with trailing diluted EPS at -$4.06 after impairments.
Cash flow is lighter. In fiscal Q1 2027, operating cash flow was negative $4.2 million and free cash flow was negative $127.9 million after $123.7 million of CapEx. Cash on hand fell 46.77% to $371.6M. Management says seasonal inventory builds use up cash in the first half.
Even so, the reduced dividend costs about $334 million a year. That has to come out of the same cash that pays about $360M in interest, about $550M in capex and roughly $250 million in planned debt paydown. Conagra also bought back $44 million of stock in the quarter.
Leverage Is What Forced the First Cut Net leverage ended the quarter at 3.99x, and management expects about four times at fiscal year end against a three times target. On the call, management said it is “maniacally focused on getting there as soon as possible.” Total liabilities stand at $11.30 billion, while shareholders’ equity fell 28.16% to $6.4 billion. Near-term maturities look manageable. Debt is “pretty much 100% fixed,” and a $500 million note issued in July at 5.4% pre-funded maturing bonds.
Volume Is the One Thing That Has to Turn Around Organic volume fell 2.1% in Q1. Revenue has now declined for four straight quarters: -5.8%, -6.8%, -1.9% and -1.4%. Guidance projects organic net sales to change by -3% to -1% this year, with Q2 expected at -2%. Inflation is running toward the higher end of the 5% to 6% range, and transportation costs have effectively doubled versus plan. Conagra is raising prices to offset that, but it models two-to-one elasticity in frozen, which means every price increase costs volume. Lower volume spreads fixed plant costs over fewer units, and margins shrink. Operating income already fell 22.74%, and Q2 operating margin is guided to the higher-single-digit range versus 11.5% in Q1.
What Has to Go Right for the Payout to Hold The bull case starts with earnings. Q1 adjusted EPS of 41 cents beat the 28.15-cent estimate. Ardent Mills equity earnings rose 71.8% to $50 million, and Foodservice grew 3.2%. The beat has asterisks, though.
About 3 cents came from SG&A timing and one-time items, Ardent’s trading gains are hard to forecast, and most SKU reduction savings won’t arrive until fiscal 28. Staples companies with long dividend records usually protect the payout by cutting elsewhere first, and Conagra still has room to pause buybacks or trim capex before touching the dividend again. For the payout to hold, cost savings and tariff relief have to restore margins, and volume has to stabilize. Analysts remain cautious: 10 Hold ratings, three Sell ratings and two Strong Sell ratings, with a $14.32 average target.
1 Signal That Settles the Question Fiscal year-end net leverage needs attention against the roughly 4.0x guide. If volume keeps falling and leverage finishes above that level despite second-half cash inflows, coverage of even the reduced dividend starts to look thin. A double-digit trailing yield on a stock that just halved its payout is the classic setup, and we listed the indicators that confirm a cut is coming in a free dividend traps report.
Conagra’s shareholders have already seen that a dividend cut rarely saves the share price. The remaining 5.28% yield needs to be judged on volume, cash flow and leverage. A yield by itself doesn’t justify a purchase.
Contact [email protected] for any questions or corrections.
Oceaneering International těží z růstu podmořské robotiky, svého největšího segmentu z hlediska tržeb, a zlepšuje provozní marže i provozní peněžní tok.
SummaryOceaneering International receives a buy rating, challenging the neutral Wall St. consensus, driven in part by market momentum and robust macro demand.OII has outperformed the S&P 500 and energy sector benchmarks this year, with subsea robotics as its largest and fast-growing revenue segment.Strong ROE, improving operating margins, and rising operating cash flow underpin durability, despite sector volatility and a sub-investment-grade credit rating.I expect meaningful capital growth through 2027, with OII positioned as a compelling growth idea rather than a dividend play. piola666/E+ via Getty Images
An Offshore Services Firm with $4.5B in Market Cap, Awaiting Q3 Earnings Results Looking out at the ocean, which I often do in between writing business articles, I thought about more than just waves and seagulls, because my
1.99K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Objednávková kniha společnosti Onto Innovation ve 2. čtvrtletí 2026 vzrostla na 1,1 mld. USD. Firma zvýšila výhled růstu tržeb ve druhém pololetí na více než 25 % oproti prvnímu pololetí.
Key Takeaways ONTO's backlog surged to $1.1B in Q2 2026, improving visibility into future demand.Management raised second-half 2026 revenue growth guidance to more than 25% over the first half.Dragonfly orders topped $200M from one OSAT partner, while silicon photonics orders exceeded $50M. Onto Innovation Inc. (ONTO - Free Report) is positioning itself for another strong growth year as rising AI infrastructure spending fuels demand for advanced semiconductor packaging and process control solutions. ONTO’s backlog has more than doubled, rising from nearly $500 million reported after the fourth quarter of 2025 to $1.1 billion in the second quarter of 2026, reflecting stronger customer commitments and improved visibility into future demand.
Management attributed the increase to customers placing orders earlier than historically typical to secure equipment supplies for their expansion plans. ONTO expected to deliver 60–70% of the backlog in the remainder of 2026, with the balance covering 2027. Customers are placing orders earlier to secure capacity for multi-year expansion plans, especially in advanced packaging where visibility has historically been shorter. Management raised its second-half 2026 revenue outlook to growth of more than 25% over the first half compared with the prior expectation of 15%.
Discussions with customers remain constructive for 2027 and volume purchase agreement negotiations are beginning for that year. This combination of broader end-market exposure, longer order visibility and rising customer commitments supports a more durable growth profile and provides a clearer base for capacity planning decisions. ONTO’s Dragonfly inspection business is driven by 2.5D packaging and HBM demand, prompting management to raise its 2026 advanced packaging growth outlook to approximately 80%. The company secured more than $200 million in Dragonfly orders from a single OSAT partner, mostly for 2027 delivery.
Adoption of the Atlas G6 platform and more than $50 million in silicon photonics orders, alongside a potential served market exceeding $500 million by 2030, provide additional growth opportunities. With Dragonfly G5 gaining traction, advanced packaging demand accelerating and new opportunities emerging in silicon photonics, ONTO expects its growth momentum to extend into 2027.
Intensifying Rivalry Tests ONTO’s Growth PotentialKLA Corporation (KLAC - Free Report) is well-positioned to outperform as AI infrastructure spending broadens demand for process control across leading-edge logic, memory and advanced packaging. KLA now expects 2026 wafer fabrication equipment spending in the low-$150 billion range, up from $135-$140 billion at its March Investor Day. Management has discussed a roughly $190 billion scenario for 2027 and expects growth at least comparable with 2026. Backlog exceeded $12 billion in August, supporting shipment visibility through 2027 and, in some cases, early 2028. KLA’s differentiated portfolio, operating leverage and capital-return framework support long-term earnings growth.
Applied Materials (AMAT - Free Report) is receiving longer planning signals from customers as advanced semiconductor supply remains tight. Its largest customers are providing rolling eight-quarter forecasts, and some discussions now extend to 2030. AMAT has nearly doubled manufacturing space over the past several years and plans to double quarterly system output from current levels by 2028. It added more than 1,500 manufacturing and AGS support employees in the fiscal third quarter and is planning further capacity for demand through 2030. This visibility can improve supply-chain readiness and execution across customer ramps. It now expects advanced packaging revenue to grow more than 70% in 2026, up from its prior outlook of more than 50%.
ONTO Price Performance, Valuation and EstimatesONTO’s shares have soared 141.2% in the past year compared with the Zacks Nanotechnology industry’s growth of 149%. The Zacks Computer and Technology sector and the S&P 500 composite have risen 32.1% and 21.3%, respectively, in the period.
Image Source: Zacks Investment Research
In terms of forward price/earnings, ONTO’s shares are trading at 26.89X, higher than the industry’s 5.4X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for ONTO has moved up for both 2026 and 2027 over the past 60 days.
Image Source: Zacks Investment Research
Onto Innovation currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Analytici očekávají, že Home BancShares ve čtvrtletí dosáhne zisku 0,64 USD na akcii a tržeb ve výši 293 milionů USD, což představuje meziroční nárůst o 4,9 %, respektive 5,5 %.
In its upcoming report, Home BancShares (HOMB - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.64 per share, reflecting an increase of 4.9% compared to the same period last year. Revenues are forecasted to be $293 million, representing a year-over-year increase of 5.5%.
The consensus EPS estimate for the quarter has been revised 0.1% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Home BancShares metrics that Wall Street analysts commonly model and monitor.
According to the collective judgment of analysts, 'Net Interest Margin (FTE)' should come in at 4.5%. The estimate compares to the year-ago value of 4.6%.
The collective assessment of analysts points to an estimated 'Efficiency Ratio' of 41.7%. The estimate compares to the year-ago value of 40.2%.
Based on the collective assessment of analysts, 'Average Balance - Total interest-earning assets' should arrive at $21.78 billion. The estimate compares to the year-ago value of $19.94 billion.
The consensus estimate for 'Total non-performing loans' stands at $90.55 million. Compared to the current estimate, the company reported $85.21 million in the same quarter of the previous year.
Analysts predict that the 'Total non-performing assets' will reach $134.79 million. Compared to the present estimate, the company reported $126.48 million in the same quarter last year.
The consensus among analysts is that 'Total Non-Interest Income' will reach $49.48 million. The estimate compares to the year-ago value of $51.51 million.
Analysts forecast 'Net Interest Income' to reach $242.80 million. The estimate compares to the year-ago value of $226.17 million.
The average prediction of analysts places 'Net Interest Income (FTE)' at $245.38 million. Compared to the current estimate, the company reported $229.08 million in the same quarter of the previous year.
It is projected by analysts that the 'Mortgage lending income' will reach $5.41 million. Compared to the present estimate, the company reported $4.69 million in the same quarter last year.
View all Key Company Metrics for Home BancShares here>>>
Home BancShares shares have witnessed a change of -4.3% in the past month, in contrast to the Zacks S&P 500 composite's +1.3% move. With a Zacks Rank #2 (Buy), HOMB is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
